James D. Kellner MD

1

Curriculum Vitae Date of Last Revision – June 14, 2015

I. Biographical Data Name: James Duncan Kellner Office Address: Department of Pediatrics Alberta Children's Hospital 2888 Shaganappi Trail NW Calgary, Alberta T3B 6A8 Contact: Telephone 403-955-7802 (administrative assistant)

403-955-7803 (direct) Fax 403-955-3065 Email Jim.Kellner@albertahealthservices.ca Citizenship: Canadian Date & place of Birth: March 26, 1959, Edmonton, Alberta Rank: Professor (with tenure) Departments: Pediatrics,

Microbiology, Immunology and Infectious Diseases, Community Health Sciences

Faculty: Cumming School of Medicine, University of Calgary Position: Professor and Head, Department of Pediatrics Institutions: University of Calgary and Alberta Health Services – Calgary Zone.

II. Academic Record Final Degrees 1984 Doctor of Medicine, University of Calgary. 1998 Masters of Science (Clinical Epidemiology), University of Toronto. Undergraduate 1981 Bachelor of Science (with Distinction), University of Alberta, Edmonton. Graduate Training 1984-86 First and Second Year Pediatric Resident, Alberta Children's Hospital, Calgary. 1986-87 Post-Core Pediatric Resident, The Hospital for Sick Children, Toronto. 1987-88 Chief Pediatric Resident, The Hospital for Sick Children. 1988-89 Fellow in Emergency Pediatrics, The Hospital for Sick Children. 1993-95 Clinical Fellow in Pediatric Infectious Diseases, The Hospital for Sick Children. 1995-96 Research Fellow in Pediatric Infectious Diseases, The Hospital for Sick Children.

James D. Kellner MD

2

Licensure and Boards 1988- Licentiate, The Medical Council of Canada. 1988- Fellow in Pediatrics, The Royal College of Physicians and Surgeons of Canada. 1988-97 General License, #57359, The College of Physicians and Surgeons of Ontario. 1990- License for Pediatrics, #010172, Alberta College of Physicians and Surgeons. 1995- Certificate of Special Competence in Infectious Diseases, The Royal College of Physicians and

Surgeons of Canada.

III. Awards and Distinctions

1978, 81 Dean's List for Honours, University of Alberta, Edmonton. 1984 Class Historian, University of Calgary Faculty of Medicine. 1988 The Pagurian Award for Excellence in Clinical Teaching by a Senior Resident, voted by the housestaff

of The Hospital for Sick Children, Toronto. 1990 Finalist nominee, The Harry Bain Award for Excellence in Clinical Teaching by a Fulltime

Pediatrician, voted by the housestaff of The Hospital for Sick Children. 1992 Clinical Teacher of the Year Award, voted by the housestaff of the Alberta Children’s Hospital. 1993 Award of Appreciation, University of Calgary Emergency Medicine Residency Program. 1996 University of Toronto Infectious Diseases Research Day Competition, First Prize. 2000 Calgary Medical Students Association (Class of 2001) Letter of Excellence in Teaching, Human

Development Course. 2001 Calgary Medical Students Association (Class of 2002) Letter of Excellence in Teaching, Human

Development Course. 2003 Calgary Medical Students Association (Class of 2004) two Letters of Excellence in Teaching,

Infant/Child Course – lectures and small groups. 2010 Clinical Infectious Diseases Award for Outstanding Review, awarded by editors and associate editors. 2011 Elected as Fellow, Infectious Diseases Society of America (FIDSA).

IV. Academic and Hospital Appointments

1989-90 Assistant Professor, Faculty of Medicine, Dept. of Pediatrics, University of Toronto. 1989-90 Active Attending Medical Staff, Emergency Department, Hospital for Sick Children, Toronto. 1990-93 Assistant Professor, Faculty of Medicine, Department of Pediatrics, University of Calgary. 1990-93 Active Attending Medical Staff, Alberta Children's Hospital Emergency Department. 1996-2000 Assistant Professor, Faculty of Medicine, Departments of Pediatrics and Microbiology and Infectious

Diseases, University of Calgary. 1996-99 Active Attending Medical Staff, Alberta Children's Hospital Emergency Department (part-time). 1996- Consultant, Division of Infectious Diseases, Alberta Children's Hospital and Regional Division of

Infectious Diseases, Calgary Health Region. 2000-05 Associate Professor, Faculty of Medicine, Departments of Pediatrics and Microbiology and Infectious

Diseases, University of Calgary. 2004-08 Head, Division of Pediatric Infectious Diseases. 2005- Professor, Faculty of Medicine, Department of Pediatrics and Department of Microbiology and

Infectious Diseases (renamed Microbiology, Immunology and Infectious Diseases in 2011), University of Calgary.

2005-08 Deputy Head (Research and Administration), Department of Pediatrics. 2008- Professor, Department of Community Health Sciences, University of Calgary. 2008- Professor and Head, University of Calgary Department of Paediatrics and Regional Clinical

Department Head Calgary Health Region Department of Pediatrics (renamed Alberta Health Services – Calgary Zone in 2009).

V. Educational Activities i. Undergraduate 1999 Supervisor summer student, Nadeem Jadavji, University of Calgary (June-August) on project:

Epidemiology of S. pneumoniae in Calgary.

James D. Kellner MD

3

2000-04 Supervisor summer student, Hiu Yee Kwok, University of Calgary (May-August each year) on projects: Studies of antibiotic resistance, epidemiology of S. pneumoniae.

2001 Supervisor Microbiology student, Anna Koscianski, on summer project and course project: Molecular epidemiology of S. pneumoniae in Canadian children.

2003-04 Supervisor summer student, Andrew Wong, University of Calgary (May-August each year) on project: Epidemiology of S. pneumoniae in Calgary.

2007-08 Supervisor summer student, Aditi Amin, University of Calgary (May-August each year) on project: Epidemiology of S. pneumoniae in Calgary.

2010 Supervisor summer student Colin Weaver, University of Calgary on project: Trends in risk factors and outcome of invasive pneumococcal infections in Calgary since 1998. Recipient of AI-HS Summer Studentship and Markin Undergraduate Student Research Program Studentship.

2011 Supervisor summer student, Melissa Wood, University of British Columbia, on project: Clinical features and outcome of serotype 19A invasive pneumococcal disease (IPD) in Calgary. Recipient of AI-HS Summer Studentship.

2015 Supervisor summer student, Lauren Zwicker, St. Francis Xavier University on project: Correlation between invasive disease and nasopharyngeal colonization serotypes of Streptococcus pneumonia in Calgary. Recipient of Maternal, Newborn, Child & Youth Strategic Clinical Network – ACHRI Scholars Training Program Summer Studentship.

iia. Graduate Teaching 1996- Lecturer, Pediatric Residents Core Teaching Rounds. Various topics. 1996-99 Lecturer and preceptor, Emergency Medicine Residents Core Lecture Series. Various topics. 1998 Lecturer, Med Sci 613.01 “Epidemiology of Infectious Diseases”. 1998-2008 Lecturer, Med 308 - Blood System, "Encapsulated Bacterial Infections". 1999- Lecturer, Med 412 - Human Development Course, renamed Course 6, "Vaccines" and "Cervical

Adenitis" 2000-2006 Lecturer, Med 302 – Principles of Medicine “Influence of Vaccines on Upper Respiratory Infections,”

“Pandemic Influenza.” 2000 Lecturer, MDSC 612 – Medical Microbiology, “Toxin Mediated Infections.” 2004-08 Lecturer, MDSC 612 – Medical Microbiology, “Streptococcal Infections” and “Staphylococcal

Infections.” iib. Graduate Supervision and Mentorship 1996- Medical Student Faculty Advisor – Suzanne Vaillancourt (1996-2000), Christopher Pruzinkiewicz

(1997-2000), Regina Liu (1998-99), Ian Jorgensen (2001-2004), Hélène Muenier (2002-2005), Ramm Hering (2003-2006).

1997-99 Supervisor, Sean Bagshaw, U of C medical student, on project: Beliefs and behaviours of parents in different care settings regarding antibiotic use by children. Peer-reviewed manuscript published.

1997-99 Supervisor, Bobbi-Jo Whitfield, U of C medical student, on project: Attitudes, beliefs and behaviours of pharmacists about herbal medicines and other alternative therapies.

1998 Supervisor, Sarah Tyler, U of Saskatchewan medical student, on summer student project, “Hepatotoxicity of Antibiotics.”

1999 External examiner, Leanne Kmet, MSc thesis in U of C Department of Community Health Sciences, “Motor vehicle crash hospitalization rates among children and youth in Alberta, Canada: urban-rural differences.”

2000 External examiner, Dr. Rob Harrop, MSc thesis in U of C Department of Community Health Science, “Native Indian status as a factor associated with injury-related mortality in Alberta children.”

2000 Supervisor, Vinita Dubey, U of C medical student, on project, “Anti-vaccination information on the Internet.” Presentation made at Canadian National Immunization Conference 2000.

2001 Supervisor, Shalini Desai , U of Toronto medical student, on project: Population-based, age-specific myringotomy rates in children in Calgary. Manuscript published, PIDJ.

2002 External examiner, Dr. Sakina Raj, MSc thesis in U of C Department of Community Health Sciences, “Economic Evaluation of Five Strategies for the Prevention of Neonatal Group B Streptococcus Disease in Alberta.”

2003-06 Committee member, Dr. Rupesh Chawla, MSc thesis in U of C Department of Community Health Science, “Invasive Fungal Infections in Bone Marrow Transplant Patients at ACH.”

2003 External examiner, Dr. Sandra Arnold, MSc thesis in U of Toronto Graduate Department of Health Policy, Management and Evaluation. “The Impact of Diagnostic Uncertainty on Antibiotic Prescribing for Pediatric Respiratory Tract Infection.”

James D. Kellner MD

4

2004 Supervisor, Janice Pitchko, on Practicum II project in U of Toronto Graduate Department of Community Health Master of Health Science-Community Health and Epidemiology Specialization. “Trends in Incidence of Invasive Pneumococcal Disease in the Calgary Health Region, 1998-2003.”

2005 Supervisor, Tara Chobotuk, U of Alberta medical student on summer student project, “Influenza Vaccination For Young Children: Parental Beliefs and Behaviors.” Manuscript published, CCDR.

2009-12 Supervisor, Leah Ricketson, U of C Department of Community Health Science MSc thesis, “Early and Late Mortality in Invasive Pneumococcal Disease in Adults in Calgary.”

2010-13 Committee member, Paul Adamiak, U of C Department of Microbiology, Immunology and Infectious Diseases MSc thesis, “Patterns of Sequence and Structural Variation within the Neisseria meningiditis Transferrin and Lactoferrin Receptor Systems.

2011-13 Committee member, Ari Morgenthau, U of C Department of Microbiology, Immunology and Infectious Diseases MSc thesis, “The Role of Lactoferrin Binding Protein B in Gram Negative Infections.”

2012-15 Supervisor, Jason Cabaj, U of C Department of Community Health Science MSc, “Underlying Risk Conditions in Persons with Invasive Pneumococcal Disease Before and After the Introduction of Pneumococcal Conjugated Vaccines (PCVs).”

2012 Supervisor, Melissa Wood, U of A medical student on MD with Special Training in Research project, “Trends in Asymptomatic Nasopharyngeal Colonization with Streptococcus pneumoniae after the Introduction of the Second-Generation 13-Valent Pneumococcal Conjugate Vaccine in Calgary, Canada.” Recipient of AI-HS Summer Studentship.

iii. Postgraduate 1997 Supervisor, Todd Sorokan (Neonatology Fellow) “Lumbar punctures in the first few days of life.”

Non-peer-reviewed manuscript published, Pediatr & Child Health. 1998-99 Co-supervisor (with HD Davies) of Jane Cunningham (Internal Medicine Resident and ID Fellow),

“Disseminated Bacille Calmette-Guérin (BCG) infection in an infant with a novel deletion in the interferon-gamma receptor gene.” Manuscript published, Int J Tuberculosis & Lung Disease.

2000 Supervisor of Rupesh Chawla (Pediatrics Resident) on project, “Conjunctivitis in children.” Manuscript published, Pediatr & Child Health.

2000-04 Supervisor of Rupesh Chawla (Infectious Diseases Fellow) on project, “Streptococcus pneumoniae Epidemiology in Calgary.” Two presentations at 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Toronto.

2000 Supervisor of Jane Cunningham (Infectious Diseases Fellow) on project, “Predicting Multidrug Nonsusceptible Streptococcus pneumoniae.” Presentation at 40th ICAAC, Toronto.

2000-02 Supervisor of Laura Sauve (Pediatrics Resident) on project, “Molecular Epidemiology of Streptococcus pneumoniae Nasopharyngeal Carriage in Children in Daycare.”

2000-04 Supervisor of Joseph Vayalumkal (Pediatrics Resident) on project, “Survey of Canadian Physicians on Tympanocentesis for Otitis Media.” Peer-reviewed manuscript published, Arch Ped Adol Med.

2000-07 Co-supervisor (with David Johnson) of Rob Tingley (Infectious Diseases Fellow) and Kelly Millar (Emergency Fellow) on project, “Management of Peritonsillar Abscesses in Children in Calgary.” Presentation at 2003 PAS meeting, Seattle and manuscript published, Pediatric Emergency Care 2007.

2001-02 Supervisor of Osama Albaksami (Infectious Diseases Fellow) on project, “Invasive Streptococcus anginosis Infections in Calgary.”

2001-03 Supervisor of Otto Vanderkooi (Infectious Diseases Resident) on project, “Invasive Streptococcus pneumoniae Causing Hemolytic Uremic Syndrome in Children.” Manuscript published, Can J Infect Dis. 2001-06 Co-supervisor (with Jean-Francois Lemay) of Katharine Smart (Pediatrics Resident) on project,

“Survey of Pediatric Residents on Antibiotic Prescribing Practices.” Manuscript published, Pediatrics and Child Health.

2003-06 Supervisor of Shalini Desai (Pediatrics Resident) on project, “Trends in Antibiotic Prescribing for Respiratory Tract Infections for Preschool Canadian Children: What Has Changed from 1995 to 2002?” Poster presented at 2004 ICAAC, Washington.

2006-08 Supervisor of Loreto Twele (Infectious Diseases Fellow) on project, “Trends in Pneumonia Presentations in Children in Calgary Before and After the Introduction of Pneumococcal Conjugate Vaccine.”

2013-16 Co-Supervisor (with Dr. Suzanne Tough) of Dr. Shannon MacDonald for AI-HS Clinician Fellowship and CIHR Fellowship on project, “Do Current Immunization Delivery and Surveillance Systems Adequately Promote and Measure Uptake of the Measles, Mumps, Rubella and Varicella (MMR-V) Vaccine?”

James D. Kellner MD

5

iv. Continuing Education and Invited Addresses 1988-90 Instructor, Hospital for Sick Children Pediatric Advanced Life Support Courses. 1989 Jan. Toronto General Hospital Paramedic Programme Continuing Medical Education. "Pediatric

Resuscitation." Toronto. April Canadian Association of Emergency Physicians, Pediatric Advanced Life Support Course. Course

Faculty. Banff, Alberta. April The Hospital for Sick Children, Annual Pediatric Update. "Recognition and Initial Management of

Shock in Children." Toronto. Oct. Alberta Children's Hospital, Invited Lecture. "Recognition and Initial Management of Shock in

Children." Calgary. 1990 Jan. Ontario Camping Association Annual Conference. "Medical Issues Affecting Camps: What’s New?

What's Different? What's Topical?" Toronto. March Hospital for Sick Children quadrennial Pediatric Emergencies Conference. “Workshop on

Cardiovascular Emergencies.” Toronto. April University of Alberta, 18th Charles T. Fried Postgraduate Pediatric Symposium. "Upper Airway

Emergencies", "Recognition and Treatment of Shock", "The Unconscious Child" and "Submersion Injuries." Edmonton.

1991 Feb. Alberta Children’s Hospital, Grand Rounds. “Corticosteroids in the Emergency Department.” Sept. Canadian Association of Pediatric Hospitals Annual Meeting. “Progress and Development in the

Emergency Department.” St. John’s, Newfoundland. Dec. Sundre and Area Family Physicians Update. “What’s New in Emergency Pediatrics?” Sundre,

Alberta. 1992 Feb. Alberta Children’s Hospital, Grand Rounds, “Outpatient Management of Serious Infections.” May Fourth International Conference on Emergency Medicine. “Analgesia and Sedation for Pediatric Pain

and Procedures.” Washington, D.C. Aug. Nanton and Area Family Physicians Update. “Advances in Pediatric Emergency Medicine.” Nanton,

Alberta. Sept. Foothills Hospital Family Practice Program. “Emergency Management of Pediatric Asthma.”

Calgary. Sept. University of Calgary Telemedicine CME Program. “Topics in Emergency Pediatrics.” Nov. Alberta Children’s Hospital, Grand Rounds, “Pain Management in the Pediatric Emergency

Department.” 1993 Jan. Calgary Emergency Medicine Exchange Rounds, “Pain Management in the Pediatric Emergency

Department.” Feb. Alberta College of Family Physicians Annual Conference, “Pediatric Pain Management.” Banff. Feb. Round Table Discussion on Pediatric Asthma, “Treatment of the Non-Responder.” Toronto. April University of Calgary Therapeutics Course, “Analgesia for Painful Pediatric Procedures: Recent

Issues.” May University of Calgary Telemedicine CME Program. “Topics in Ambulatory Pediatrics.” 1995 Feb. University of Ottawa Combined Infectious Diseases Rounds. "Pneumococcus Infections in Children

in Day-Care." Ottawa. Dec. British Columbia Children's Hospital Research Institute Seminars. "Nasopharyngeal Carriage of

Pneumococcus: Implications for Middle Ear and Invasive Infections." Vancouver. 1996 Feb. University of Toronto 9th Annual Update in Emergency Medicine. "Life-Threatening Exanthems" and

"The Crying Infant." Whistler, British Columbia. Mar. Alberta Children's Hospital Grand Rounds. "Streptococcus pneumoniae infections: 1996 Update."

Calgary. June First Canada-China Satellite Medical Conference. "Antibiotic Resistance in Children in Child Care

Centres in Canada." Toronto and seven centres in China. 1997 Jan. Calgary Regional Health Authority Nursing Update I. "Case studies in Sepsis." Calgary. Feb. Child Health Research Unit Rounds. "Development of a Meta-analysis." Calgary. Mar. Calgary Regional Health Authority Nursing Update II. "Case studies in Sepsis." Calgary.

James D. Kellner MD

6

Sept. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Satellite Symposium: Antibiotic Resistance in Children: What Do We Know and What Can We Do? “Research on Antibiotic Resistant S. pneumoniae in Children in Child Care Centres." Toronto.

Oct. University of Calgary and Calgary Regional Health Authority Pediatrics Update '97. "Serious Group A Streptococcus Infections" and "Community Acquired Pneumonia." Calgary.

Dec. Pediatric Supper Club. "Community Acquired Pneumonia." Edmonton. 1998 Jan. Peter Lougheed Centre Medical Grand Rounds. "Update on Pneumococcal Infections." Calgary Mar. Pediatric Workshop. "Respiratory Tract Infections in Children: Impact of Antibiotic Resistance on

Management of Respiratory Infections in Children" and "Fever Without Source." Emerald Lake, British Columbia.

Mar. 15th Calgary Therapeutics Course. “Management of Pneumonia and Otitis Media in Children.” April 4th Child Health Research Symposium. “Great Debate: All Cases of Acute Otitis Media must be

Treated” and “Worldwide Influenza Surveillance” and “Workshop: Hands-on Introduction to SPSS.” Calgary.

April Alberta Children’s Hospital Medical Grand Rounds. “Impact of Antibiotic Resistance on Management of Respiratory Infections in Children." Calgary.

May 20th Community and Hospital Infection Control Association National Conference. “Antibiotic Resistance in the Community.” Kananaskis, Alberta.

June B. C. Children’s Hospital Research Seminar Series. “Beyond the serotype: studies in the molecular epidemiology of Streptococcus pneumoniae.” Vancouver, British Columbia.

Sept. Pfizer Western Canada Staff Meetings. “Trends in Antibiotic Resistance.” Calgary. Sept. Alberta Pediatric Society Annual Meeting. “Community Acquired Pneumonia.” Calgary. Nov. Abbott Family Practice Workshop. “Management of Otitis Media.” Canmore. Dec. Calgary Laboratory Services Technicians Seminar. "Streptococcus pneumoniae Infections." Calgary. Dec. Calgary Regional Health Authority Nursing Update. "Case studies in Sepsis." Calgary. 1999 Feb. 8th International Pediatric Infectious Diseases Course. "A Practical Approach to the Child with Fever

and Petechiae" and "Bacterial and Viral Eye Infections Seen in Your Office - Which Need Treatment?" Banff.

Mar. Infectious Diseases Research Group Seminar. "Studies in the Epidemiology of Streptococcus pneumoniae." Calgary

Mar. 16th Calgary Therapeutics Course. "Workshop on Antibiotic Resistance." Calgary. April 5th Child Health Research Symposium. "HIV does not cause AIDS - An example of a Logical Fallacy."

Calgary. April Abbott Family Practice Workshop. “Management of Otitis Media.” Canmore. June University of Calgary Pediatrics Update. "Immunization Update." Calgary. Sept. Glaxo Wellcome Prairie Provinces Staff Meetings. "Antibiotic Resistance: Mechanisms, Prevalence

and Strategies to Reduce." Banff Oct. Pfizer Fall Pediatric Exchange. "Antibiotic Resistance in Community Acquired Pathogens: Current

Trends" "Development of Clinical Practice Guidelines." Banff. Oct. Child Health Research Unit Seminar. “Streptococcus pneumoniae Nasopharyngeal Carriage in Child

Care Centres.” Calgary. 2000 Jan. Abbott Market Access Group. “Antibiotic Resistance in Canada.” Vancouver. Jan. Pfizer Pediatric Preceptorship Program in Infectious Diseases. “Antibiotic Resistance.” Toronto. Feb. 9th International Pediatric Infectious Diseases Course. "The 10 Commandments of Appropriate

Antibiotic Use." Banff. Feb. 8th Annual Western Perinatal Research Meeting. "Congenital Infections as the Causation of IUGR."

Banff. March 17th Calgary Therapeutics Course. "Vaccine Update" and "Workshop on Otitis Media: To Treat or

Not to Treat." Calgary. May Consensus Meeting on Management of Pneumonia in Children. “Trends in Bacterial Resistance and

Vaccine Update.” Toronto. May 54th Annual Meeting, Canadian Society of Otolaryngology – Head and Neck Surgery. “Canadian

Trends in Resistance, Outcome of Resistant Infections and Trends in Antibiotic Prescribing.” Toronto. June 2000 Canadian Pediatric Society Annual Meeting Satellite Symposium. “Antibiotic Resistance in

Community Pathogens: Outcomes and Current Trends.” Ottawa. Oct. Pfizer Pediatric Preceptorship Program in Infectious Diseases. “Trends in Antibiotic Resistance and

Outcomes.” Edmonton.

James D. Kellner MD

7

Oct. Alberta Children’s Hospital Grand Rounds. “Trends in Antibiotic Resistance and Outcomes.” Calgary.

Oct. Infectious Diseases Research Group Seminar. Epidemiology of S. pneumoniae in Calgary. Nov. Okanagan Valley Pediatricians’ Monthly Rounds. “Trends in Antibiotic Resistance in Community

Acquired Pathogens in Canada: Implications for Management.” Kelowna, BC. Dec. Fourth Canadian National Immunization Conference Satellite Symposium on Pneumococcal Disease

Prevention. “Management and Outcome of Penicillin-Nonsusceptible Streptococcus pneumoniae Meningitis in Canada.” Halifax.

2001 Feb. 10th International Pediatric Infectious Diseases Course. "The Promise of Pneumococcal Conjugate

Vaccines." Banff. March Canadian Association of Emergency Physicians Annual Meeting. Cutting Edge Debate, “Otitis Media

– To Treat or Not to Treat.” Calgary. April Child Health Research Group Seminar. “Case-Control Study of Penicillin-Nonsusceptible

Pneumococcal Meningitis in Canadian Children.” Calgary. May Second Health Canada Pandemic Influenza Contingency Planning Meeting. “Clinical Care

Guidelines.” Montreal. May Alberta Children’s Hospital Grand Rounds. “Pneumococcal Conjugate Vaccines: Great Promise, at a

Price.” Calgary. May Foothills Professional Building Physician’s Seminar. “Pneumococcal Conjugate Vaccines.” Calgary. May Lethbridge Physicians Evening Seminar. “Pneumococcal Conjugate Vaccines.” Lethbridge. Sept. McGill Conference on Meningococcal Disease in the Era of New Vaccines. “Prioritizing New

Vaccines: The Case for Pneumococcal Conjugate Vaccine.” Montreal. Nov. Pfizer Therapeutic Update. “Local Antibiotic Resistance Update: A Pediatric Perspective.” Calgary. Nov. University of Saskatchewan Department of Pediatrics Grand Rounds. “The Promise of Pneumococcal

Conjugate Vaccines.” Saskatoon. Nov. University of Saskatchewan Department of Pediatrics Special Rounds. “Management of Otitis Media

in 2001.” Pediatric Residents Case Rounds. “Meningitis.” Saskatoon. Nov. Pfizer Pediatric Preceptorship Program for Rural Pediatricians. “Trends in Antibiotic Resistance and

Outcomes.” Calgary. Nov. U of C Faculty of Medicine Evening Course. “Three New Immunizations.” Calgary. 2002 Jan U of C Department of Community Medicine Continuing Education Seminar. “Pneumococcal and

Meningococcal Infections: Epidemiology, Clinical Features and Prevention in 2002.”Calgary with simultaneous Web-Broadcast across Alberta.

Feb. 11th International Pediatric Infectious Diseases Conference. "Update on the Prevention and Management of Meningococcal Infections." Banff.

Feb. Health Canada National Immunization Strategy Program Planning Meeting. “Evaluation of Pneumococcal Conjugate Vaccine.” Toronto.

Mar. U of C Teleconference Program. “Vaccination Issues and Update.” Two teleconferences broadcast to several Southern Alberta centers from Calgary.

Mar. 19th Calgary Therapeutics Course. “New Vaccines: Pneumococcal and Meningococcal Conjugate Vaccines.” Calgary.

Mar. Pfizer Pediatric Advisory Board. “History of Short-Course Antibiotic Therapy in Pediatric Respiratory Tract Infections.” Lake Louise.

May Canadian Laboratory Medicine National Congress. “Progress in Prevention and Treatment of Meningitis.” Calgary.

May Bayer Libra Antibiotic Utilization Planning Meeting. “Issues in Pediatric Antibiotic Prescribing and Resistance in Canada.” Toronto.

May Citywide Division of Infectious Diseases Faculty Seminar. “Update on Pneumococcal Vaccines.” Calgary.

June 79th Canadian Pediatric Society Annual Meeting Pediatric Update. “Pneumococcal Conjugate Vaccine: It’s Working and It Should Be Used Routinely.” Toronto.

June U of C Infectious Diseases Research Group Seminar. “Trends in Antibiotic Resistance in Gram-Positive Bacteria in Calgary.” Calgary.

Aug. Calgary Health Region Division of General Pediatrics Seminar. “How Long Should Common Respiratory Infections Be Treated For? Calgary.

Oct. Pfizer Education Beyond Medication Family Practice Seminar. “Management of Otitis Media in 2002.” Banff.

James D. Kellner MD

8

Oct. McGill Infectious Diseases Conference: Diagnosis, Detection and Management of Gram Positive Infections. “Pneumococcal Infections: Update on Antibiotic Resistance and Prevention.” Mont Tremblant, Quebec.

Dec. Pfizer Western Canada Annual Staff Meeting. “Antibiotic Resistance and Other Issues in the Management of Otitis Media.” Banff.

Dec. Family Practice Update. “Update on the Impact and Potential Benefits of Pneumococcal Conjugate Vaccine.” Calgary.

2003 Feb. VoxMedic E-learning Web-Based Conferences. “Current Issues in the Treatment of Pediatric Otitis

Media.” Three conferences, each with ~25 pediatricians or family physicians from all across Canada. Mar Citywide Division of Infectious Diseases Faculty Seminar. “Acute Sore Throat in 2003: Does Everyone

Need a Throat Swab?” Calgary. Apr 20th Calgary Therapeutics Course. “Vaccines: What is the Current Schedule; When to Recommend

Vaccines That are Not Part of the Schedule.” Calgary Apr Alberta Children’s Hospital Grand Rounds. “Progress in Prevention and Management of Bacterial

Meningitis.” Calgary. Apr Edmonton General Pediatricians Monthly Meeting. “Management of Fever in the Community in

2003: Are the Times A-Changin’?” Edmonton. June U of C Pediatric Update Course. “Update on Immunization Programs in Alberta.” Calgary. June 80th Canadian Pediatric Society Annual Meeting, Satellite Symposium. “The Burden of

Pneumococcal Disease.” Calgary. June South Calgary Family Practice Study Group. “Update on Immunizations.” Calgary. Oct Alberta Children’s Hospital Emergency Department Rounds. Management of Fever in Children in

2003: Are the Times A-Changin’?” Calgary. Nov Citywide Otolaryngology Rounds. “Trends in Antibiotic Resistance in Respiratory Tract Infections.”

Calgary. Dec U of C Evening Course. “Immunization Update: What Immunizations are Recommended for

Children and Adults?” Calgary. 2004 Feb 13th International Pediatric Infectious Diseases Conference. “Using Antibiotics Wisely: Where are We

in 2004?” Banff. Mar 21st Calgary Therapeutics Course. “What Happens When We Stop Immunizing: A Cautionary Tale.”

Calgary. Apr Red Deer Regional Conference Program. “Update on Immunizations.” Red Deer. May CIDS/CHICA/CAMM National Conjoint Conference. Pneumococcal Infections in Canada in the Era

of the Pneumococcal Conjugate Vaccine: Good News and Bad News. Calgary. May Ste. Justine Hospital Combined Infectious Diseases and Microbiology Rounds. “Impact of

Pneumococcal Conjugate Vaccine in Canada: What Can We Expect & What Do We Already Know?” Montreal.

May Montreal Children’s Hospital Infectious Diseases Rounds. “Impact of Pneumococcal Conjugate Vaccine in Canada: What Can We Expect & What Do We Already Know?” Montreal.

June 81st Canadian Pediatric Society Annual Meeting, Satellite Symposium. “Impact of Pneumococcal Conjugate Vaccine in Canada: What do We Know?” Montreal.

Sept Citywide Division of Infectious Diseases Seminar. “CASPER and Friends: Update on Pneumococcal Epidemiology Research.” Calgary.

Oct 6th Alberta Society of Infectious Diseases Annual Conference. “Streptococcus pneumoniae Infections in Alberta: Impact of Old and New Vaccines.” Kananaskis.

Dec 6th Canadian National Immunization Conference. “Pneumococcal Conjugate Vaccine: Are We Getting What We Are Paying For?” Montreal.

2005 Feb Canadian Pediatric Society Lifelong Learning in Pediatrics Course. “Infectious Diseases

Emergencies.” Banff. June Public Health Agency of Canada Goals and Objectives Consensus Conference, Vaccine Preventable

Diseases. “Impact of Pneumococcal Conjugate Vaccine (PCV7) in Canada.” Quebec City. June First Annual Robert Tingley Lecture, Atlantic Health Sciences Department of Pediatrics.

“Pneumococcal Conjugate Vaccine: Effective But Is It Worth The Price?” Saint John, New Brunswick. June 82nd Canadian Pediatric Society Annual Meeting, Satellite Symposium. “Impact of Pneumococcal

Conjugate Vaccine In Canada.” Vancouver. June 82nd Canadian Pediatric Society Annual Meeting, Satellite Symposium. “Guidelines For Treatment

of Acute Otitis Media In Canada.” Vancouver.

James D. Kellner MD

9

Dec Institute of Maternal and Child Health Seminar. “Progress in the Prevention of Pneumococcal Infections: Two Steps Forward?” Calgary.

2006 Feb 15th International Pediatric Infectious Diseases Conference. “Impact of Conjugate Vaccines.” Banff. Feb Wyeth Annual Medical Marketing and Managing Director Meeting. “Potential and Promise of

Prevenar.” San Francisco. June Alberta Children’s Hospital Grand Rounds. “Progress in the Prevention of Pneumococcal Infections:

Two Steps Forward?” Calgary. June 83rd Canadian Pediatric Society Annual Meeting, Satellite Symposium. “Pneumococcal

Immunization: Impact on Herd Immunity and Special Populations.” St. John’s. Oct European Academy of Pediatrics Meeting Satellite Symposium. “Impact of Prevenar (PCV7) in North

America.” Barcelona, Spain. Nov U of C Evening Course. “Fever, Aching, Sniffling, Coughing and Diarrhea: Is it “The Flu”, “A Flu” or

Something Else?” Calgary. Dec 7th Canadian Immunization Conference Plenary Session. “Pneumococcal Conjugate Vaccine –

Canadian Experience.” Winnipeg. 2007 Jan Calgary Public Health Nurses Update Day. “A Potpourri of Pneumococcal News: Impact of

Pneumococcal Conjugate Vaccine on Colonization and Invasive Disease and a Recent Western Canadian Epidemic.” Calgary.

Feb 16th International Pediatric Infectious Diseases Conference. “New Vaccines: Human Papillomavirus, Meningococcus and Rotavirus.” Banff.

Feb U of C CME Collaborative Video Conference Program. “New Vaccines: Human Papillomavirus and Rotavirus.” Calgary.

Mar 24th Calgary Therapeutics Course. “Rotavirus Vaccine.” Calgary. June 84th Canadian Pediatric Society Annual Meeting, Satellite Symposium. “Preventing Pneumonia in

Children: Another Role for the Pneumococcal Conjugate Vaccine?” Montreal. Oct Department of Medicine Grand Rounds. “Forget Harry Potter vs Voldemort: The Non-Fiction Story

of How Vaccinating Children for Pneumococcal Infections is Preventing the ‘Captain of the Men of Death.’” Calgary.

2008 Jan Alberta Children’s Hospital Grand Rounds. “Pneumococcal Infections in 2008: Making Progress

Against an Old Foe.” Calgary. May Alberta Provincial Laboratory of Public Health Centennial Scientific Symposium. “From Variola to

Condyloma: A Short History of Vaccination.” Edmonton. June 85th Canadian Pediatric Society Annual Meeting, Satellite Symposium. “Serotype Replacement and

the Future of Pneumococcal Conjugate Vaccines.” Victoria. Dec Canadian Association for Immunization Research and Evaluation (CAIRE) Research Workshop.

“Why Study Pneumococcal Nasopharyngeal Colonization: Results from the CASPER Study.” Toronto.

Dec 8th Canadian Immunization Conference Satellite Symposium. “Changing Epidemiology of Pneumococcal Disease in Infants and Children.” Toronto.

Dec 8th Canadian Immunization Conference Concurrent Session. “New Vaccine Programs: Measuring the Clinical and Economic Impact.” Session Chair and Presenter, “Surveillance Systems for Vaccine Preventable Diseases in Canada.”

2009 June 26th International Congress on Chemotherapy. “Childhood Vaccines: Science Meeting the Challenge

of Prevention: Symposium Chair and Presenter, “The Changing Epidemiology of Pneumococcal Infections After the Introduction of Pneumococcal Conjugate Vaccine.” Toronto.

Aug American Academy of Pediatrics District VIII Annual Meeting. “Welcome and Description of Pediatric Services in Calgary.” Calgary.

Nov Wyeth Pneumococcal Conjugate Vaccines: Bridging to the Future. “Preventing Pneumococcal Disease II – Impact of PCV7 National Immunization Programs in the Rest of the World.” Rome.

2010

James D. Kellner MD

10

June 87th Canadian Pediatric Society Annual Meeting, Satellite Symposium. “Current Epidemiology of Invasive Pneumococcal Disease in Children: Implications for Expanded Valency Vaccines.” Vancouver.

July Expert Consultation on Changing Epidemiology of Pneumococcal Serotypes Following Conjugate Vaccine Introduction. “Epidemiology of Invasive Pneumococcal Disease in Calgary, Canada, 1998 – 2009. WHO/Gates Foundation, Geneva, Switzerland.

Nov Infectious Disease Update – Global, Tropical and Travel Medicine, Satellite Session. “Serotype Epidemiology in Pneumococcal Disease in Children.” Victoria.

Dec 9th Canadian Immunization Conference. “Debate: Review of the Epidemiology of Pneumococcal Disease in Canada and New Conjugate Vaccines.” Quebec City.

2011 Feb 20th International Paediatric Infectious Diseases Conference. “Optimizing Prevention of

Pneumococcal and Meningococcal Infections.” Banff. June 88th Canadian Pediatric Society Annual Meeting, Concurrent Session. “So You Want to Be an

Academic Pediatrician?” (with Dr. Denis Daneman) Quebec City. 2012 June 89th Canadian Pediatric Society Annual Meeting, Concurrent Session. “Ding, Dong, the Triple Threat

is Dead, or is it?” (with Dr. Denis Daneman) London, Ontario. Dec 10th Canadian Immunization Conference, Canadian Pediatric Society-Pfizer Symposium.

“Nasopharyngeal Colonization and Herd Effect of Vaccines.” Vancouver. 2013 Feb 22nd International Paediatric Infectious Diseases Conference. “Optimizing Prevention of Pneumococcal

and Meningococcal Infections.” Banff. Mar Citywide Infectious Diseases Rounds. “Fifteen Years of Studying the Pneumococcus in Calgary.”

Calgary May First Department of Pediatrics Update Conference. “Vaccines: Too Many or Not Enough?” Calgary. May Pediatric Neurology Central Nervous System Infectious Diseases Symposium. “Update on Bacterial

Meningitis.” Calgary. June 90th Canadian Pediatric Society Annual Meeting, Seminar. “Today’s Paediatricians: Treating Disease

or Ensuring Health?” (with Drs. Denis Daneman and Jean-Yves Frappier) Edmonton, Alberta. 2014 Mar Western Canada Immunization Forum. “Impact of Pneumococcal Conjugate Vaccines.” Edmonton. Mar Western Canada Immunization Forum. “Vaccines: Too Many or Not Enough.” Edmonton. 2015 Feb 24th Annual Paediatric Infectious Diseases Conference. “Impact of Pneumococcal Conjugate Vaccines

on Burden of Diseases.” Banff.

VI. Administrative Responsibilities

i. Departmental 1990-92 Assistant Director, Emergency Department, Alberta Children’s Hospital. 1992-93 Acting Director, Emergency Department, Alberta Children’s Hospital. 1996-02 Member, Child Health Research Unit Executive Committee. 1997-06 Member, Child Health Scientific Review Committee (Chair from 2001-2004, Past Chair 2004-06). 1998 Member, Academic Priorities Review Committee (ad hoc). 1999 Member, Clinical Teaching Unit Review Committee (ad hoc). 2000-05 Member, Child Health Research Centre Executive Committee (Chair from 2002-05). 2000-01 Member, Pediatric Residency Training Committee. 2000-04 Director, Pediatric Infectious Diseases Fellowship Program. 2001-02 Member, Alternate Funding Plan Committee. 2002- Member, Alternate Funding Plan Steering Committee, Chair from 2007-08. Renamed AARP Management Committee in 2009 2002-08 Chair, Alternate Funding Plan Accountability Committee.

James D. Kellner MD

11

2003-05 Member, Institute of Maternal and Child Health Steering Committee. 2004-08 Head, Division of Pediatric Infectious Diseases. 2005-08 Associate Director, Institute of Maternal and Child Health. 2005-08 Deputy Head (Research and Administration), Department of Pediatrics. 2008- Professor and Head, Department of Pediatrics. 2008- Chair, Pediatric Executive Committee, renamed Zone Pediatric Executive Committee in 2011. 2008- Member, Childhood Cancer Collaborative Steering Committee. ii. Faculty/University 1997-99 Faculty of Medicine Representative to Faculty of Social Work. 1997-98 Member, Selection Committee for Head, Department of Pediatrics. 1999-04 Member, Human Development Course Curriculum Committee (Infant, Child & Adolescent section). 1999-01 Member, Selection Committee for Pediatric Oncologist. 2000-04 Member, Student Academic Review Committee. 2002 Chair, Committee to Review Pediatric Clinical Clerkship Exam (ad hoc). 2005- Member, Institute of Maternal and Child Health Executive Committee. Renamed Alberta Children’s Hospital Institute for Child and Maternal Health Leadership Council in 2009. 2005-08 Member, Student Affairs Committee. 2008- Professor and Head, Department of Paediatrics. 2008- Member, Faculty Leadership Forum. 2008- Member, Faculty Department Heads Committee. 2010-14 Member, Faculty Planning and Priorities Committee. 2012-13 Chair, Provincial Advisory and Operations Committee (PAOC) for the Province-wide Academic

Alternate Remuneration Plan (P-AARP). iii. Calgary Health Region (to 2009)/Alberta Health Services – Calgary (2009 onwards) 1997-01 Member, Regional Blood Transfusion Committee. 1998 Member, Alberta Children’s Hospital Isolation Unit Planning Group (ad hoc). 2000 Member, Public Health Laboratory User/Communication Group (ad hoc). 2001 Member, Pandemic Influenza Health Services Subcommittee. 2008- Regional Clinical Department Head, Pediatrics, renamed Zone Clinical Department Head 2009. 2008- Member, Regional/Zone Clinical Department Heads Committee. 2008- Member, Medical Advisory Board, renamed Zone Medical Advisory Committee in 2011. 2008-11 Member, AHS Women and Children’s Integration Team, renamed Child Health Working Group 2009

VII. Professional Activities

i. Memberships 1984- Canadian Pediatric Society, Section on Emergency Pediatrics from 1989-99. 1984- Canadian Medical Protective Association, membership #705152. 1988- Canadian Medical Association, Alberta Medical Association from 1990. 1992- Alliance for the Prudent Use of Antibiotics. 1993- Pediatric Infectious Diseases Society. 1993- American Society for Microbiology. 1994- Canadian Infectious Diseases Society. 1994- Infectious Diseases Society of America. 1997- Emerging Infectious Diseases Network. ii. Professional Service Grant Reviews 1997- Alberta Children's Hospital Foundation. 1997- The Hospital for Sick Children Foundation. 1999 Saskatchewan Health Services Utilization and Research Commission. 2000 Canadian Infectious Diseases Society. 2003- Physicians’ Services Incorporated Foundation. 2004- Thrasher Foundation, Salt Lake City, Utah. 2005- Canadian Institutes of Health Research. 2005 Heart and Stroke Foundation of Canada. 2006 Canadian National Immunization Conference.

James D. Kellner MD

12

Grant Review Committees 1997- Alberta Children’s Hospital Foundation (Regular Grants & Small Grants). 2006 Canadian Institutes of Health Research (Microbiology & Infectious Diseases). 2006 Canadian Institutes of Health Research (Pandemic Influenza). 2007- Michael Smith Foundation for Health Research. Journal Reviews & Conference Abstract Reviews 1996- Archives of Pediatric and Adolescent Medicine. 1996- Canadian Journal of Infectious Diseases and Medical Microbiology. 1998 International Journal of Infectious Diseases. 1998- Pediatrics. 1998- Paediatrics and Child Health. 1999 Pediatric Research. 2000 Journal of American Medical Women’s Association. 2001- Clinical Infectious Diseases. 2001- BioMedCentral. 2001- Journal of Infectious Diseases. 2001 Expert Opinion on Pharmacotherapy. 2002 Journal of Antimicrobial Chemotherapy. 2002- Journal of Clinical Microbiology. 2004- Pediatric Infectious Diseases Journal. 2004- Antimicrobial Agents and Chemotherapy. 2004- Canadian Journal of Public Health. 2004 European Journal of Clinical Microbiology and Infectious Diseases. 2004- Canadian National Immunization Conference (abstract reviews). 2005 Pediatric Blood and Cancer. 2005- Clinical and Diagnostic Laboratory Immunology. 2007- Annals of Epidemiology. 2010- Vaccine. 2013- Journal of the Pediatric Infectious Diseases Society. 2014- PLoS Medicine.

Editorships

1998-2005 Editorial Group Member, Cochrane Collaboration Acute Respiratory Infections Review Group. 2008-11 Editorial Board, Pediatric Infectious Disease Journal. 2009-13 Associate Editor, Paediatrics, The Canadian Journal of Infectious Diseases and Medical Microbiology. Community, Provincial, National & International Organizations 1990-95 Executive Committee, Canadian Pediatric Society Section on Emergency Pediatrics. Vice-chair, 1992-

1993. 1991-96 Examiner, The Royal College of Physicians and Surgeons of Canada for Fellowship in Emergency

Medicine. 1998- Associate Investigator (Pneumococcal Project), Immunization Monitoring Program, Active

(IMPACT). 2000-03 Health Canada Population and Public Health Branch, Pandemic Influenza Contingency Planning:

Chair, Clinical Subgroup; Member, Health Services Working Group. 2001-03 Canadian Infectious Diseases Society Program Planning Committee. 2001-04 Alberta Pandemic Influenza Contingency Planning: Chair, Clinical Subcommittee; Member, Health

Services Subcommittee. 2002-04 Member, Pediatric Infectious Diseases Society International Affairs Committee. 2002-08 Member, Pediatric Investigators’ Collaborative Network on Infections in Canada (PICNIC) Executive

Committee. 2002- Member, Alberta Health & Wellness Advisory Committee on Communicable Disease Control (Chair

starting in 2006). Renamed Alberta Advisory Committee on Immunization 2010. 2004-06 Fifth International Symposium on Pneumococci and Pneumococcal Diseases, International Scientific

Committee. 2006-09 Member, Pediatric Infectious Diseases Society Clinical Affairs Committee. 2006-09 Member, National Centre for Streptococcus Scientific Advisory Committee.

James D. Kellner MD

13

2007-10 Member, PneumoADIP (Pneumococcal Vaccine Accelerated Development and Implementation Plan) External Expert Committee to the Global Serotype Project.

2007-14 Member, Canadian Association for Immunization Research and Evaluation (CAIRE) Steering Committee.

2007-08 Member, National Advisory Committee on Immunizations (NACI). 2008- Member, NACI Pneumococcal Working Group. 2007- Member, External Expert Advisory Committee, Human Papillomavirus Vaccine Project, Michael

Smith Foundation for Health Research, Vancouver. 2008- Member, Alberta Children’s Hospital Foundation Board of Directors. 2008- Member, Paediatric Chairs of Canada (Member, Executive Committee from 2009). 2009- Member, Canadian Association of Paediatric Health Centres (CAPHC) Board of Directors. 2010- Member, Public Health Agency of Canada Enhanced National Surveillance for Invasive

Pneumococcal Disease Technical Advisory Committee. 2011- Member WHO Serotype Replacement Technical Advisory Group. 2011-13 Vice-President, Pediatric Chairs of Canada. 2013- President, Pediatric Chairs of Canada.

James D. Kellner MD

14

VIII. Research Support i. Peer-Reviewed Grants 1989-90 The Role of Oxygen in the Treatment of Painful Crises in Sickle Cell Anemia. Investigators: JD Kellner, IC Robieux, NF Olivieri, G Koren, MJ Coppes, B Brown, A. Zipursky. Funding: $6500, The Hospital for Sick Children Pediatric Consultants. 1991 Utilization of Pediatric Emergency Departments. Investigators: JD Kellner, G Moineau, L Chauvin-Kimoff, L Bird, D Jaffe. Funding: $7500, The Alberta Children’s Hospital Foundation. 1995-96 Canadian Infectious Diseases Society Research Fellowship. Funding: $42,585, Canadian Infectious Diseases Society. 1997-98 Invasive and Nasopharyngeal Isolates of Streptococcus pneumoniae: Correlation of Serotypes and Pulsed-Field Gel Electrophoresis (PFGE) Patterns. Investigators: JD Kellner, A McGeer, DE Low, EL Ford-Jones, HO Davies, M Lovgren, A Matlow, J Talbot, J Wenger, B Willey. Funding: $40,800, Alberta Children's Hospital Foundation. 1998-99 Population-Based Survey of Trends and Cohort Analytic Study of Outcome of Invasive Streptococcus pneumoniae Infections. Investigators: JD Kellner, DL Church, EE Wang, DE Woods. Funding: $19,726, Alberta Children's Hospital Foundation. 1998-99 Pharmacokinetics of Platinum drugs Combined with Mesna (2-mercaptoethanesulphonate sodium) Investigators: JEA Wolff, R Anderson, MJ Coppes, M Egeler, S Iceton, JD Kellner, V Sorensen. Funding: $17,992, Alberta Children’s Hospital Foundation. 2000-01 Molecular Epidemiology of Invasive Streptococcus pneumoniae Infections in Canadian Children: Searching for Virulent Clones. Investigators: JD Kellner, AJ McGeer, D Greenberg, DW Scheifele, DE Low. Funding: $44,750, Alberta Children's Hospital Foundation. 2000 Studies of Antimicrobial Resistance. Investigator: JD Kellner. Funding: $5000, Calgary Regional Health Authority Summer Student Award (Hiu Yee Kwok, U of Calgary undergraduate). 2005-06 Knowledge, Attitudes and Beliefs about Childhood Immunizations and the Immunization Experience in Treaty 7 First Nations Communities: A Pilot Study Investigators: JD Kellner, R Hering. Funding: $2000. Alberta Children’s Hospital Foundation Small Grants Competition. 2006-07 Innate Immunity, Toll-Like Receptor Signaling and Susceptibility to Pneumococcal Infection. Investigators: S Turvey (PI, University of British Columbia), JD Kellner (collaborator). Funding: $93,952. Canadian Institutes of Health Research (Pilot Project Grant – New Investigators in Infection and Immunity).

James D. Kellner MD

15

2006-08 CIHR Team in Pediatric Emergency Medicine. Project 6: Exploring Novel Methods to Improve our Diagnostic Accuracy of Childhood Bacterial Pneumonia. Investigators: T Klassen (Team PI, University of Alberta), DW Johnson (University of Calgary) & T Lynch (University of Western Ontario) (Project Co-Leaders), JD Kellner (Project Investigator) and others. Funding: $199,801 (for Project 6). Canadian Institutes of Health Research Team Grant Competition. 2008-13 AHFMR Interdisciplinary Team Grant in Vaccine Design and Implementation. Co-Team Leaders: A Schryvers, JD Kellner, L Babiuk Funding: $5,000,000. Alberta Heritage Foundation for Medical Research Interdisciplinary Team Grant Competition. 2008-10 CIHR Team in Influenza Vaccine Technologies (CTIVT) Investigation of Novel Vaccine Strategies for Influenza: Targeting Innate and Adaptive Immunity for Cross-Protective Vaccines. Investigators: B Agrawal (Team PI, U of Alberta), C Richardson (Co-PI), R Kumar (Co-PI), J Smit, D Kobasa JD Kellner (End-User). Funding: $396,050. Canadian Institutes of Health Research Institute of Infection and Immunity Team Grant: Pandemic Preparedness – Influenza Biology, Vaccines, Ethics, Legal and Social Research Competition. 2009-14 Evaluation of Meningococcal C Conjugate Vaccine Programs in Canadian Children. Investigators: JA Bettinger (PI, UBC), G De Serres, SR Dobson, SA Halperin, JD Kellner, DW Scheifele, AB Schryvers. Funding: $699,663. CIHR Institute of Population and Public Health Operating Grant. 2009-10 Accuracy of Metabolomics for Diagnosing Pediatric Pneumonia Investigators: JD Kellner (PI), T Lynch, DW Johnson, A Nettel-Aguirre, T Marrie, C Slupsky. Funding: $50,000. Alberta Children’s Hospital Foundation and $30,000. The Lung Association, Alberta and NWT, National Grant Review Competition. 2009-12 PHAC/CIHR Influenza Research Network Principal Investigators: SA Halperin, RA Bortolussi, JP Collet, G De Serres, MM Johnson, JC Kwong, SA McNeil, DW Scheifele, BJ Ward. JD Kellner (Co-Investigator) Funding: $13,974,459. Canadian Institutes of Health Research Institute of Infection and Immunity & Public Health Agency of Canada. 2010-15 CIHR Emerging Team Grant: Canadian Microbiome Initiative Principal Investigators: DME Bowdish, AB Schryvers, MG Surette. Co-Investigators: J Johnstone, JD Kellner. Funding: $1,783,223. 2011-14 CIHR Partnerships for Health System Improvements (PHSI): The Implementation and Evaluation of an Alberta Childhood Asthma Clinical Pathway. Principal Investigators: DW Johnson, C Westerlund. JD Kellner (Co-Investigator) Funding: $350,000 (plus $150,000 matching funds from AHS). 2014-19 Alberta Provincial Paediatric EnTeric Infection Team (APPETITE): Epidemiology, Emerging Organisms and Economics. Collaborative Lead: SB Freedman. Collaborative Co-Leads: B Lee, M Louie, XL Pang. JD Kellner (Co-Investigator). Funding: $4,998,400. AIHS, CRIO Team.

James D. Kellner MD

16

ii. Investigator Initiated Grants-in-Aid 1995-96 Streptococcus pneumoniae Nasopharyngeal Carriage in Children in Child Care Centres in Toronto: Point Prevalence, Serotypes and Antimicrobial Resistance Patterns. Investigators: JD Kellner (Co-PI), EL Ford-Jones (Co-PI), A Matlow, M Corey, D Low, R Gold. Funding: $107,405, Lederle Praxis Biologics Inc, USA (Grant-in-aid). 1996 Streptococcus pneumoniae Antimicrobial Resistance Patterns. Investigators: JD Kellner, EL Ford-Jones, D Low. Funding: $24,000, Pfizer Canada Inc (Grant-in-aid). 1997-98 Macrolide Resistance in Streptococcus pneumoniae. Investigators: JD Kellner, DE Low, J de Azavedo. Funding: $27,300, Pfizer Canada Inc (Grant-in-aid). 1997-98 Surveys of Antibiotic Prescription Patterns Using Saskatchewan Drug Databases. Investigators: EEL Wang, T Einarson, JD Kellner, J Conly. Funding: $30,000, Abbott Laboratories, $10,000, Hoechst Marion Roussel Canada, $10,000, Bristol-Myers Squibb Canada (Grants-in-aid). 1998 Antibiotic-Induced Liver Toxicity Investigator: JD Kellner. Funding: $3680, MRC-Burroughs Wellcome Student Research Award (Sarah Tyler, U of Saskatchewan medical student), $6000, Pfizer Canada (Grant-in-aid). 2003-05 Impact of Routine Infant Immunization with the Pneumococcal Conjugate Vaccine (PCV7) on Streptococcus pneumoniae Nasopharyngeal Carriage and Invasive Disease. Investigators: JD Kellner, DL Church, J MacDonald, D Scheifele, J Sampalis. Funding: $600,000. Wyeth Pharmaceuticals (Grant-in-aid). 2003-04 Trends in Antibiotic Prescribing for Respiratory Tract Infections for Preschool Canadian Children: What Has Changed from 1995 to 2002? (Survey of Saskatchewan Health Records Databases) Investigators: S Desai, JD Kellner, J Conly, Y Shevchuk. Funding: $25,000. Pfizer Pharmaceuticals (Grant-in-aid). 2004-05 CASPER-PCV (Calgary Area Streptococcus pneumoniae Epidemiology Research Pneumococcal Conjugate Vaccine) Study. Investigators: JD Kellner, DL Church, J MacDonald, D Scheifele. Funding: $55,000. Wyeth Pharmaceuticals (Grant-in-aid). 2005-07 Invasive Pneumococcal Disease in Alberta: Changing Epidemiology in the Era of Conjugate Vaccines. Investigators: Greg Tyrrell (PI), JD Kellner, T Marrie, K Grimsrud. Funding: $415,980. Wyeth Pharmaceuticals (Grant-in-aid). 2006-07 CASPER-PCV7 Study: Continued Surveillance for Invasive Pneumococcal Disease. Investigators: JD Kellner, DL Church, J MacDonald, D Scheifele, O. Vanderkooi. Funding: $86,040. Wyeth Pharmaceuticals (Grant-in-aid). 2006-07

James D. Kellner MD

17

CASPER-PCV7 Study: Continued Evaluation of Trends in Nasopharyngeal Carriage. Investigators: JD Kellner, DL Church, J MacDonald, D Scheifele, O. Vanderkooi. Funding: $35,750. Wyeth Pharmaceuticals (Grant-in-aid). 2007-08 CASPER-PCV (Calgary Area Streptococcus pneumoniae Epidemiology Research – Pneumococcal Conjugate Vaccine) Study: Surveillance and Analysis of Invasive Pneumococcal Disease and Pneumonia. Investigators: JD Kellner, DL Church, J MacDonald, D Scheifele, O. Vanderkooi. Funding: $386,800. Wyeth Pharmaceuticals (Grant-in-aid). 2009-10 CASPER-PCV (Calgary Area Streptococcus pneumoniae Epidemiology Research – Pneumococcal Conjugate Vaccine) Study III: Continuation of Surveillance and Analysis of Invasive Pneumococcal Disease in Canada. Investigators: JD Kellner, O. Vanderkooi, DL Church, J MacDonald, D Scheifele. Funding: $304,064. Wyeth Pharmaceuticals (Grant-in-aid). 2010-12 CASPER-PCV (Calgary Area Streptococcus pneumoniae Epidemiology Research – Pneumococcal Conjugate Vaccine) Study: Continuation of Evaluation of Trends in Nasopharyngeal Colonization in Canada. Investigators: JD Kellner, O. Vanderkooi, DL Church, J MacDonald, D Scheifele. Funding: $123,736. Wyeth Pharmaceuticals (Grant-in-aid). 2011-13 CASPER-PCV (Calgary Area Streptococcus pneumoniae Epidemiology Research-Pneumococcal Conjugate Vaccine) Study IV – Continuation of Surveillance and Analysis of Invasive Pneumococcal Disease (IPD) and Pneumococcal Related Disease (PRD) in Canada. Investigators: JD Kellner, DL Church, J MacDonald, D Scheifele, OG. Vanderkooi. Funding: $649,146. Pfizer Pharmaceuticals (Investigator Initiated Research). 2012-15 Immunization of Women with Diphtheria and Tetanus Toxoids Combined with Acellular Pertussis (Tdap) During the Mid Third Trimester of Pregnancy: An Evaluation of the Potential for Immunological Protection for the Neonate. Investigators: Halperin S (PI); Vanderkooi OG & Dwinnell S (Site co-PIs); Kellner JD, Wilson RD, MacDonald J, Kuhn S (Site co-investigators) Funding (local): $213,685. Canadian Centre for Vaccinology, Dalhousie University, Sanofi Pasteur (Investigator Initiated Research). 2014-16 CASPER-PCV (Calgary Area Streptococcus pneumoniae Epidemiology Research-Pneumococcal Conjugate Vaccine) Study V – Continuation of Surveillance and Analysis of Invasive Pneumococcal Disease (IPD), Pneumococcal Related Disease (PRD) and Nasopharyngeal (NP) Colonization in Canada. Investigators: JD Kellner, OG Vanderkooi, DL Church, J MacDonald. Funding: $742,037. Pfizer Pharmaceuticals (Investigator Initiated Research). iii. Contracts 1998-99 Multicenter, Randomized Controlled Trial of Pleconaril in the Treatment of Enteroviral Meningitis in Children and Adolescents. Investigators: JM Rogers and others. Local Co-Investigators: HD Davies, JD Kellner. Funding: (Local budget) $38,500, ViroPharma Incorporated (Contract). 1999-2002 Antimicrobial Resistance in Oropharyngeal Bacteria after Macrolide Antibiotic Treatment. Investigators: JD Kellner, DE Low, DL Church, ML Aufricht, WJ McIsaac. Funding: $168,000, Abbott Laboratories Canada (Contract).

James D. Kellner MD

18

2001 Meningovax: Natural Anti-Meningococcal Antibody Response in Invasive Meningococcal Infection in Children and Adolescents less than 20 Years of Age. Investigators: D Greenberg and others. Local investigator: JD Kellner. Funding: (Local budget) $11,163. Aventis Pasteur (Contract). 2001 Randomized, Blinded, Placebo-Controlled Cross-Over Study Evaluating Incidence of Oculo-Respiratory Syndrome (ORS) Following Intramuscular Administration of Fluviral® S/F Vaccine for 2001-2002 to Healthy Adults 30-59 Years of Age Who Did Not Have ORS Last Season – Protocol SBI FLUVIRAL-01-01. Investigators: D Scheifele and others. Local Investigator: MR Russell. Local Co-Investigators: HD Davies, JD Kellner, J MacDonald. Funding: (Local Budget) $109,006. SHIRE Biologics (Contract). 2001 Randomized, Blinded, Placebo-Controlled Cross-Over Study of the Safety of Fluviral® S/F Vaccine (2001-2002 Season) in Adults Who Experienced Oculo-Respiratory Syndrome in the 2000-2001 Season Following Administration of Fluviral® S/F Vaccine – Protocol SBI FLUVIRAL-01-02. Investigators: D Scheifele and others. Local Investigator: MR Russell. Local Co-Investigators: HD Davies, JD Kellner, J MacDonald. Funding: (Local Budget) $30,703. SHIRE Biologics (Contract). 2001 EPI 20: Pneumococcal Surface Proteins Distribution in Pneumococcal Disease Affecting Adults Over 50 Years of Age in Australia, Europe and North America. Investigators: S Hollingshead and others. Local Investigator: JD Kellner. Funding: (Local Budget) $15,000. Aventis Pasteur (Contract). 2003-04 A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR versus Amoxicillin for the Treatment of Group A Beta-hemolytic Streptococcal Pharyngitis/Tonsillitis in Children. Investigators: C Galos and others. Local Investigators: JD Kellner, P Aufricht and others. Funding: $24,750. Pfizer Pharmaceuticals (Contract). 2003-04 A Multi-National, Prospective Cohort Study to Evaluate the Incidence and Outcome of Staphylococcal Sepsis in Neonates With a Gestational Age Between 24 and <33 Weeks. Investigators: C Buscarino, E Areu and others. Local Investigators: JD Kellner, H Amin. Funding: $14,500. GlaxoSmithKline (Contract). 2008-09 A Phase II, Randomized, Observer-Blind, Clinical Trial to Assess the Immunogenicity and Safety of Two Dose Levels (0.25 mL And 0.50 mL) of Thimerosal-Free Fluviral® Vaccine, using a Licensed Influenza Virus Vaccine Vaxigrip® (sanofi pasteur), as the Control, Administered to Children 6 Months to less than 3 Years of Age (Protocol 111635). Site Investigators: OG Vanderkooi, JD Kellner (Site Co-Investigator), J MacDonald. Funding (local): 88,330. GlaxoSmithKline (Contract). 2007-09 A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine In Healthy Infants Given With Routine Vaccinations in Canada. (Protocol 6096A1-3008, ClinicalTrials.gov ID NCT00475033). Investigators: Scheifele D, Halperin S et al. Site Investigators: JD Kellner (PI), OG Vanderkooi. Summary: Clinical trial comparing new 13-valent vaccine with existing 7-valent vaccine. Funding (local): $344,438. Wyeth Research, Canada and USA (Contract). 2008 Clinical Study in Children, 6 Months to 3 Years of Age, To Assess the Immunogenicity and Safety of two Dose Levels of Thimerosol-Free Fluviral® Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control (Protocol GSK1557482A, ClinicalTrials.goc ID NCT00778895).

James D. Kellner MD

19

Investigators: Bouveret N, Seifert H, Gauthier JM (Vanderkooi OG, site PI, Kellner JD, site Co-Investigator). Funding (local): $103,277. GlaxoSmithKline, Canada (Contract).

James D. Kellner MD

20

IX. Publications

i. Peer-Reviewed Manuscripts (Directly supervised trainees underlined)

1. Mazzulli A, Kellner JD, Humphreys RP, Ford-Jones EL. Cerebellar abscess mimicking acute varicella-associated cerebellar ataxia: A case report. The Pediatric Infectious Disease Journal 1991;10:413-14.

2. Zipursky A, Robieux IC, Brown, EJ, Shaw D, O’Brodovich H, Kellner JD, Coppes MJ, Koren G, Olivieri NF. Oxygen therapy in sickle cell disease. American Journal of Pediatric Hematology-Oncology 1992;14(3):222-8.

3. Robieux IC, Kellner JD, Coppes M, Shaw D, Brown E, Good C, O’Brodovich H, Manson D, Olivieri NF, Zipursky A, Koren G. Analgesia in children with sickle cell crises: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation. Pediatric Hematology and Oncology 1992;9:317-26.

4. Ford-Jones EL, Kelly E, Kellner JD, Silver MM, Pastuzak A, Freedman M, Laxer R, Petric M, Logan S, Ryan G. Human parvovirus B19 infection - implications for pediatric practice. Canadian Journal of Pediatrics 1995;2:306-16.

5. Wang EL, Ohlsson A, Kellner JD. Ureaplasma urealyticum colonization is associated with chronic lung disease of prematurity: results of a meta-analysis. Journal of Pediatrics 1995;127:640-4.

6. Kellner JD, Ohlsson A, Gadomski A, Wang EL. Efficacy of bronchodilator therapy in bronchiolitis: a meta-analysis. Archives of Pediatrics & Adolescent Medicine 1996;150:1166-72.

7. Kellner JD, McGeer A, Cetron MS, Low DE, Butler JC, Matlow A, Talbot J, Ford-Jones EL. The use of Streptococcus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease. Pediatric Infectious Diseases Journal 1998;17:279-86.

8. Laupland K, Davies HD, Kellner JD, Luzod N, Karan T, Ma D, Taub D, Nijssen-Jordan C, Jadavji T, Katzko G, Church D. Predictors and outcome of admission for invasive Streptococcus pneumoniae infections at a Canadian children's Hospital. Clinical Infectious Diseases 1998;27:597-602.

9. Johnston NJ, De Azavedo J, Kellner JD, Low DE. Prevalence and characterization of the mechanisms of macrolide, lincosamide and streptogramin resistance in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 1998;42:2425-6).

10. Noyek A, Brodovsky D, Coyle S, Desrosiers M, Frenkiel S, Hawke M, Kellner JD, Kirkpatrick D, Krajden S, Low DE, Mandell L, Marlow B, Martin GF, Rival R, Shankar L, Vaughan D, Witterick I. Classification, diagnosis and management of sinusitis: evidence-based clinical practice guidelines. Canadian Journal of Infectious Diseases 1998;9 (Supplement B):1B-24B.

11. Kellner JD, Ohlsson A, Gadomski A, Wang EL. Efficacy of bronchodilator therapy in bronchiolitis: a meta-analysis. (Cochrane Review) Cochrane Library 1998;Issue 4. Oxford: Update Software.

12. Wang EEL, Kellner JD, Arnold S. Antibiotic resistant Streptococcus pneumoniae: implications for medical practice. Canadian Family Physician 1998;44:1881-8.

13. Kellner JD, Gibb AP, Zhang J, Rabin HR. Household transmission of Streptococcus pneumoniae, Alberta, Canada. Emerging Infectious Diseases 1999;5:154-8.

14. Kellner JD, Ford-Jones EL, The Toronto Child Care Centre Study Group. Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Archives of Pediatrics & Adolescent Medicine 1999;153:495-502.

15. Wang EEL, Einarson TR, Kellner JD, Conly JM. Antibiotic prescribing for Canadian preschool children: evidence for over-prescribing for viral respiratory infections. Clinical Infectious Diseases 1999;29:155-60.

James D. Kellner MD

21

16. Ausejo M, Saenz A, Pham B, Kellner JD, Johnson D, Moher D, Klassen TP. Evaluating the effectiveness of glucocorticoids in the treatment of croup: a meta-analysis of randomized controlled trials. British Medical Journal 1999;319:595-600. Reprinted in: Western Journal of Medicine 1999;171:227-32.

17. Luna VA, Jernigan DB, Tice A, Kellner JD, Roberts MC. A novel multi-resistant Streptococcus pneumoniae clone serogroup 19 from Washington State is identified by pulsed-field gel electrophoresis and restriction fragment length pattern. Journal of Clinical Microbiology 2000;38:1575-80.

18. Ausejo M, Saenz A, Pham B, Kellner JD, Johnson D, Moher D, Klassen TP. Glucocorticoids for croup (Cochrane review). Cochrane Library 2000;Issue 2. Oxford: Update Software.

19. Scheifele D, Halperin S, Pelletier L, Talbot J, Members of Immunization Monitoring Program, Active (IMPACT) (Kellner JD, member and acknowledged for editorial assistance). Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Clinical Infectious Diseases 2000;31:58-64.

20. Cunningham JA, Kellner JD, Bridge P, Trevenen CL, McLeod DR, Davies HD. Disseminated Bacille Calmette-Guérin (BCG) infection in an infant with a novel deletion in the interferon-gamma receptor gene. International Journal of Tuberculosis and Lung Disease. 2000;4:791-4.

21. Bagshaw SM, Kellner JD. Beliefs and behaviours of parents in different care settings regarding antibiotic use by children. Canadian Journal of Infectious Diseases. 2001;12:93-7.

22. Laupland KB, Davies HD, Calgary Home Parenteral Therapy Program Study Group (Kellner JD, member). Olecranon bursitis managed in an ambulatory setting. Clin Invest Med 2001;24:171-8 .

23. Chawla R, Kellner JD, Astle WF. Acute infectious conjunctivitis in childhood. Paediatrics and Child Health 2001;6:329-35.

24. Desai SN, Kellner JD, Drummond D. Population-based, age-specific myringotomy with tympanostomy tube insertion rates in Calgary, Canada. Pediatric Infectious Disease Journal 2002;21:348-50.

25. Kellner JD. Management of Bacterial Meningitis in Children (invited commentary, peer-reviewed). Paediatrics and Child Health 2002;7:447-8.

26. Kellner JD, Scheifele DW, Halperin SA, Lebel MH, Moore D, Le Saux N, Ford-Jones EL, Law B, Vaudry W, for Members of CPS/LCDC Immunization Monitoring Program, Active (IMPACT). Outcome of penicillin-nonsusceptible Streptococcus pneumoniae (PNSP) meningitis: a nested case-control study. Pediatric Infectious Disease Journal 2002;21:903-9. 27. Bjornson G, Scheifele DW, Halperin SA, for Members of CPS/LCDC Immunization Monitoring Program, Active (IMPACT) (Kellner JD, member). Population-Based Epidemiology of Invasive Pneumococcal Infection in Children in 9 Urban Centers Across Canada, 1994-1998. Pediatric Infectious Disease Journal 2002;21:947-50.

28. Ford-Jones EL, Friedberg J, McGeer A, Simpson, K, Croxford R, Willey B, Coyte P, Kellner JD, Daya H, and the Toronto ARM Study Group. Microbiologic findings and risk factors for antimicrobial resistance at myringotomy for tympanostomy tube placement: a prospective study of 601 children in Toronto. International Journal of Pediatric Otorhinolaryngology 2002;66:227-42.

29. Lebel M, Kellner JD, Ford-Jones EL, Hvidsten K, Wang ECY, Ciuryla V, Arikian S, Casciano R. A Pharmacoeconomic Evaluation of Seven-Valent Pneumococcal Conjugate Vaccine in Canada. Clinical Infectious Diseases 2003;36:259-68.

30. Kellner JD. Management of Fever without Focus: Changing Times (invited commentary, peer-reviewed). Paediatrics and Child Health 2003;8:74-5.

31. Scheifele D, Duval B, Russell M, Warrington R, DeSerres G, Skowronski D, Dionne M, Kellner JD, Davies HD, MacDonald J. Ocular and Respiratory Symptoms Attributable to Inactivated Influenza Vaccine: Evidence From a Controlled Trial in Adults. Clinical Infectious Diseases 2003;36:850-7.

James D. Kellner MD

22

32. Scheifele DW, Law B, Vaudry W, Halperin SA, Kellner JD, King A, Dawar M. Invasive Pneumococcal Infections Among Canadian Aboriginal Children. Canada Communicable Disease Report 2003;29:37-42

33. Skowronski DM, De Serres G, Scheifele D, Russell M, Warrington R, Davies D, Dionne M, Duval B, Kellner JD, MacDonald J. Randomized Double-Blind Placebo Controlled Trial to Assess the Rate of Recurrence of Oculo-Respiratory Syndrome in Persons Previously Affected following Influenza Vaccination. Clinical Infectious Diseases 2003:37:1059-66.

34. Low DE, Kellner JD, Allen U, Boucher FD, Kovesi T, Reisman J, Davidson R, Langley JM. Community Acquired Pneumonia in Children: An Update. Canadian Journal of Infectious Diseases 2003;14(Suppl B):1B-11B.

35. Vanderkooi O, Kellner JD, Wade AW, Jadavji T, Midgley (JP), Louie T, Tyrrell GJ. Invasive Streptococcus pneumoniae Causing Hemolytic Uremic Syndrome in Children: Two Cases and a Review of the Literature. Canadian Journal of Infectious Diseases 2003;14:339-43. (www.ncbi.nlm.nih.gov/pubmed/18159477)

36. Leung AK, Kellner JD. Acute Sinusitis in Children: Diagnosis and Management. Journal of Pediatric Health Care 2004;18:72-6.

37. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empiric Validation of Guidelines for the Management of Pharyngitis in Children and Adults. Journal of the American Medical Association 2004;291:1587-95. 38. Vayalumkal J, Kellner JD. Tympanocentesis for the Management of Otitis Media in Children: A Survey of Canadian Pediatricians and Family Physicians. Archives of Pediatrics and Adolescent Medicine 2004;158:962-5. 39. Leung AK, Kellner JD, Johnson DW. Viral Croup: A Current Perspective. Journal of Pediatric Health Care 2004;18:297-301. 40. Leung AK, Kellner JD. Group A Beta-Hemolytic Streptococcal Pharyngitis in Children. Advances in Therapy. 2004;21:277-87. 41. Kellner JD. Corticosteroids for Suspected Bacterial Meningitis in Children – Status in 2005. Pediatrics and Child Health 2005;10:107-8. 42. Mah JK, Kellner JD, Kunimoto D, Kaura D, Mah MH. An Infant with Central Nervous System Complications of Disseminated Tuberculosis. Canadian Journal of Neurological Sciences 2005;32:112-14. 43. Kellner JD, Church DL, MacDonald J, Tyrrell GJ, Scheifele D. Progress in the Prevention of Pneumococcal Infection. Canadian Medical Association Journal 2005;173:1149-51. (www.ncbi.nlm.nih.gov/pubmed/16275962) 44. Leung AKC, Kellner JD, Davies HD. Genital Infection With Human Papillomavirus in Adolescents. Advances in Therapy 2005;22:187-96. 45. Leung AK, Kellner JD, Davies HD. Rotavirus Gastroenteritis. Advances in Therapy 2005;22:476-87. 46. Leung AK, Kellner JD, Davies HD. Respiratory Syncytial Virus Bronchiolitis. Journal of the National Medical Association 2005;97:1708-13. 47. Leung AK, Kellner JD, Davies HD. Hepatitis A: A Preventable Threat. Advances in Therapy 2005;22:578-86. (www.ncbi.nlm.nih.gov/pubmed/16510374) 48. Kellner JD. Response to ‘Benefits of Glucocorticoids in the Treatment of Bacterial Meningitis in Children: End of the Controversy?’ Paediatrics and Child Health 2006;11:31-2. (www.ncbi.nlm.nih.gov/pubmed/19030241)

49. Hollingshead SK, Baril L, Ferro S, King J, Coan P, Briles DE and the Pneumococcal Proteins Epi Study Group (Kellner JD member). Pneumococcal Surface Protein A (PspA) Distribution Among Clinical Isolates From Adults Over 50 Years of Age Collected in Seven Countries. Journal of Medical Microbiology 2006;55:215-21. (www.ncbi.nlm.nih.gov/pubmed/16434715)

James D. Kellner MD

23

50. Chobotuk TD, Kellner JD. Influenza Vaccination For Young Children: Parental Beliefs and Behaviors. Canada Communicable Disease Report 2006:32:141-50. 51. Smart K, Lemay JF, Kellner JD. Antibiotic Choices by Pediatric Residents and Recently Graduated Pediatricians for Typical Infectious Disease Problems in Children. Paediatrics and Child Health 2006;11(10):647-53). (www.ncbi.nlm.nih.gov/pubmed/19030247) 52. Bettinger JA, Scheifele DW, Halperin SA, Kellner JD, Tyrrell G. Invasive Pneumococcal Infections In Canadian Children, 1998-2003: Implications For Vaccination Programs. Canadian Journal of Public Health 2007;98:111-5. (www.ncbi.nlm.nih.gov/pubmed/17441533) 53. Millar KR, Johnson DW, Drummond D, Kellner JD. Suspected Peritonsillar Abscess in Children. Pediatric Emergency Care 2007;23:431-8. (www.ncbi.nlm.nih.gov/pubmed/17666922) 54. Kellner JD, Scheifele D, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ. Effects of Routine Infant Vaccination with the 7-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization with Streptococcus pneumoniae in Children in Calgary, Canada. Pediatric Infectious Disease Journal 2008;27:526-32. (www.ncbi.nlm.nih.gov/pubmed/18458650) 55. Langley JM, Kellner JD, Solomon N, Robinson JL, Le Saux N, McDonald J, Ulloa-Gutierrez R, Tan B, Allen U, Dobson S, Joudrey H. Empyema associated with Community-Acquired Pneumonia: A Pediatric Investigators’ Collaborative Study on Infections in Canada (PICNIC) Study. BMC Infectious Diseases 2008;8:129. (http://www.ncbi.nlm.nih.gov/pubmed/18816409) 56. Chuck A, Jacobs P, Nguyen T, Hanrahan A, Loewen J, Mashinter L, Ohinmaa A, Zhang J, Vaudry W, Kellner JD. Economic Analysis of a Public Program for Routine Seven-Valent Pneumococcal Conjugate Vaccine (PCV7) in Infancy, Alberta Canada Communicable Diseases Report 2008;34(10):1-13. 57. Miettunen PMH, Wei X, Kaura D, Abou-Reslan WF, Nettel-Aguirre A, Kellner JD. Dramatic Pain Relief and Resolution of Bone Inflammation Following Pamidronate in 9 Pediatric Patients With Chronic Recurrent Multifocal Osteomyelitis (CRMO): An Open-Label Prospective Study of 10 Patients. Pediatric Rheumatology 2009;7:2. (http://www.ncbi.nlm.nih.gov/pubmed/19138427) 58. Leung AKC, Kellner JD, Davies HD. Chickenpox: An Update. Journal of Pediatric Infectious Diseases 2009;4:343-50. 59. Laupland KB, Gregson DB, Vanderkooi OG, Ross T, Kellner JD. The Changing Burden of Pediatric Bloodstream Infections in Calgary, Canada, 2000-2006. Pediatric Infectious Disease Journal 2009;28(2):114-7. (www.ncbi.nlm.nih.gov/pubmed/19116605) 60. Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GL, Scheifele D. Changing Epidemiology of Invasive Pneumococcal Disease in Canada 1998 to 2007: Update from the Calgary Area Streptococcus pneumoniae Research (CASPER) Study. Clinical Infectious Diseases 2009;49(2):205-12. (www.ncbi.nlm.nih.gov/pubmed/19508165) Accompanied by Editorial Commentary, Greenberg D. The Shifting Dynamics of Pneumococcal Invasive Disease after the Introduction of Pneumococcal 7-Valent Conjugated Vaccine: Toward the New Pneumococcal Conjugated Vaccines. Clinical Infectious Disesaes 2009;49(2):213-5. 61. Tyrrell GT, Lovgren M, Chui N, Minion J, Garg S, Kellner JD, Marrie TJ. Serotypes and Antimicrobial Susceptibilities of Invasive Streptococcus pneumoniae Pre and Post 7-Valent Pneumococcal Conjugate Vaccine Introduction in Alberta, Canada, 2000 to 2006. Vaccine 2009;27(27):3553-60. (www.ncbi.nlm.nih.gov/pubmed/19464534) 62. Vanderkooi OG, McConnell A, Church DL, Kellner JD. Antimicrobial Susceptibility of Invasive and Lower Respiratory Tract Isolates of Streptococcus pneumoniae, 1998-2007. Canadian Journal of Infectious Diseases and Medical Microbiology 2009;20(4):e139-44. (www.ncbi.nlm.nih.gov/pubmed/21119791) 63. Matute JD, Arias AA, Wright NAM, Wrobel I, Waterhouse CCM, Li XJ, Marchal CC, Stull ND, Lewis DB, Steele M, Kellner JD, Yu W, Merough SO, Nauseef WM, Dinauer M. A New Genetic Subgroup of Chronic Granulomatous Disease With Autosomal Recessive Defects in p40phox In A Boy Who Presented With Colitis. Blood 2009;114(15):3309-15. (www.ncbi.nlm.nih.gov/pubmed/19692703)

James D. Kellner MD

24

64. Bettinger JA, Scheifele DW, Kellner JD, Halperin SA, Vaudry W, Law B, Tyrrell G. The Effect of Routine Vaccination on Invasive Pneumococcal Infections in Canadian Children, IMPACT 2000 to 2007. Vaccine 2010;28(9):2130-6. (www.ncbi.nlm.nih.gov/pubmed/20044050) 65. Wong A, Marrie TJ, Garg S, Kellner JD, Tyrrell, GJ and the SPAT Group. Increased Risk of Invasive Pneumococcal Disease in Hematologic and Solid-Organ Malignancies. Epidemiology and Infection 2010;138(12):1804-10. (www.ncbi.nlm.nih.gov/pubmed/20429967) 66. Waisman DC, Tyrrell GJ, Kellner JD, Garg S, Marrie TJ. Pneumococcal Peritonitis: Still With Us and Likely to Increase in Importance. Canadian Journal of Infectious Diseases and Medical Microbiology 2010;21(1):e23-7. (www.ncbi.nlm.nih.gov/pubmed/21358876) 67. Chuck A, Jacobs P, Tyrrell G, Kellner JD. Pharmacoeconomic Evaluation of 10 and 13-Valent Pneumococcal Conjugate Vaccines. Vaccine 2010;28(33):5484-90. (www.ncbi.nlm.nih.gov/pubmed/20554066) 68. Wong A, Marrie TJ, Garg S, Kellner JD, Tyrrell GJ; the SPAT Group. Welders are at Increased Risk for Invasive Pneumococcal Disease. International Journal of Infectious Diseases 2010;14(9):e796-9. (www.ncbi.nlm.nih.gov/pubmed/20637673) 69. Lynch T, Bialy L, Kellner JD, Osmond MH, Klassen TP, Durec T, Leicht R, Johnson DW. A Systematic Review on the Diagnosis of Pediatric Bacterial Pneumonia: When Gold is Bronze. PLoS ONE 2010;5(8):e11989(1-7). (www.ncbi.nlm.nih.gov/pubmed/20700510) 70. Filler G, Piedboeuf B, Paediatric Chairs of Canada (Kellner JD, member). Variability of the Pediatric Subspecialty Workforce in Canada. Journal of Pediatrics 2010;157(5):844-7.e.1. (www.ncbi.nlm.nih.gov/pubmed/20955855) 71. Vanderkooi OG, Gregson DB, Kellner JD, Laupland KB. Staphylococcus aureus Bloodstream Infections in Children: A Population Assessment. Paediatrics & Child Health 2011;16(5):276-80. (www.ncbi.nlm.nih.gov/pubmed/22547946) 72. Scheifele DW, Ward BJ, Dionne M, Vanderkooi O, Langley JM, Dobson S, Li Y, Law B, Halperin SA, for the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Rapid Trials Investigators (Kellner JD, member). Evaluation of Adjuvanted Pandemic H1N12009 Influenza Vaccine After One and Two Doses in Young Children. Pediatric Infectious Disease Journal 2011;30(5):402-7. (www.ncbi.nlm.nih.gov/pubmed/21178654) 73. Vanderkooi OG, Church DL, MacDonald J, Zucol F, Kellner JD. Community-Based Outbreaks in Vulnerable Populations of Invasive Infections caused by Streptococcus pneumoniae Serotypes 5 and 8 in Calgary, Canada. PLoS ONE 2011;6(12):e28547. (www.ncbi.nlm.nih.gov/pubmed/22216100) 74. Johnstone J, Tyrrell GT, Marrie TJ, Garg S, Kellner JD, Streptococcus pneumoniae Alberta Team (SPAT). Streptococcus pneumoniae Meningitis in Alberta Pre- and Postintroduction of the 7-Valent Pneumococcal Conjugate Vaccine. Canadian Journal of Infectious Diseases and Medical Microbiology. 2011;4(Winter):137-41. (www.ncbi.nlm.nih.gov/pubmed/23205025) 75. Vanderkooi OG, Scheifele DW, Girgenti D, Halperin SA, Patterson SD, Gruber WC, Emini EA, Scott DA and Kellner JD for the Canadian PCV13 Study Group. Safety and Immunogenicity of a 13 -Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given with Routine Pediatric Vaccinations in Canada. Pediatric Infectious Disease Journal 2012;31(1):72-7. (www.ncbi.nlm.nih.gov/pubmed/21960186) 76. Langley JM, Scheifele D, Quach C, Vanderkooi O, Ward B, McNeil S, Dobson S, Kellner JD, Kuhn S, Kollman T, MacKinnon-Cameron D, Smith B, Halperin SA. Safety and Immunogenicity of 2010-2011 H1N12009-Containing Trivalent Inactivated Influenza Vaccine in Children 12 to 59 Months of Age Previously Given AS03-Adjuvanted H1N12009 Pandemic Vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) Study. Vaccine 2012 May 14;30(23):3389-94. Epub 2012 Mar 30. (www.ncbi.nlm.nih.gov/pubmed/22469860) 77. Daneman D, Kellner JD. Navigating the Stages of an Academic Career for Pediatricians. Paediatrics & Child Health 2012 June/July;17(6):301-3. (www.ncbi.nlm.nih.gov/pubmed/23730164)

James D. Kellner MD

25

78. Bettinger JA, Scheifele DW, Halperin SA, Kellner JD, Vanderkooi OG, Schryvers A, De Serres G, Alcantara J. Evaluation of Meningococcal Serogroup C Conjugate Vaccine Programs in Canadian Children: Interim Analysis. Vaccine 2012;30(27):4023-7. Epub 2012 Apr 23. (www.ncbi.nlm.nih.gov/pubmed/22537988) 79. VanderPluym C, Tawfik G, Hervas-Malo M, Lacaze-Masmonteil T, Kellner JD, Robinson J. Empiric Therapy of Possible Neonatal Herpes Simplex Virus Infection. Journal of Maternal-Fetal and Neonatal Medicine 2012;25(8):1278-82. Epub 2011 Nov 10. (www.ncbi.nlm.nih.gov/pubmed/21992471) 80. Leal J, Vanderkooi OG, Church DL, MacDonald J, Tyrrell GJ, Kellner JD. Eradication of Invasive Pneumococcal Disease (IPD) Due to the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Calgary, Canada. Pediatric Infectious Disease Journal 2012;31(9):e169-75. Epub 2012 June 5. (www.ncbi.nlm.nih.gov/pubmed/22673137) 81. Scheifele JD, Dionne M, Ward BJ, Cooper C, Vanderkooi OG, Li Y, Halperin SA, PHAC/CIHR Influenza Research Network (Kellner JD, member). Safety and Immunogenicity of 2010-2011 A/H1N1pdm09-Containing Trivalent Inactivated Influenza Vaccine in Adults Previously Given AS03-Adjuvented H1N1 2009 Pandemic Vaccine: Results of a Randomized Trial. Human Vaccines and Immunotherapeutics. 2013;9(1):136-43. (www.ncbi.nlm.nih.gov/pubmed/23570051) 82. Yam KK, Gupta J, Brewer A, Scheifele DW, Halperin S, Ward BJ; Public Health Agency of Canada/Canadian Institute of Health Research, Influenza Research Network (PCIRN) Rapid Trial Study 3 (RT-03) Investigators (Kellner JD, member). Unusual Patterns of IgG Avidity in Some Young Children Following Two Doses of the Adjuvanted Pandemic H1N1 (2009) Influenza Virus Vaccine. Clinical and Vaccine Immunology. 2013;20(4):459-67. (www.ncbi.nlm.nih.gov/pubmed/23345582) 83. Feikin DR, Kagucia EW, Loo J, Link-Gelles R, Puhan M, Cherian T, Levine OS, Whitney CG, O’Brien K, Moore MR, for the Serotype Replacement Study Group (Kellner JD, member and also member of the WHO Technical Advisory Group). Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites. PLoS Medicine 2013; 10(9):e1001517. (www.ncbi.nlm.nih.gov/pubmed/24086113) 84. Ricketson LJ, Nettel-Aguirre A, Vanderkooi OG, Laupland KB, Kellner JD. Factors Influencing Early and Late Mortality in Adults with Invasive Pneumococcal Disease in Calgary, Canada: A Prospective Surveillance Study. PLoS ONE 2013;8(10):e71924. (www.ncbi.nlm.nih.gov/pubmed/24115997) 85. Filler G, Givelichian L, Walti H, Piedboeuf B, Pediatric Chairs of Canada (Kellner JD, member). Rising Part-Time Work in the Academic Pediatric Workforce in Canada. Journal of Pediatrics 2013 Aug 163(2):312-313.e2. (www.ncbi.nlm.nih.gov/pubmed/23885849) 86. Daneman D, Kellner JD, Bernstein M, Dow K, Dugas MA, Duffy C, Eddy A, Filler G, Frappier J-Y, Gilmour S, Givelichian L, Huang L, Rockman-Greenberg C, Shevell M, Vardy C, Walti H, Orrbine E, Williams M. Social Paediatrics: From 'Lip Service' to the Health and Well-Being of Canada’s Children and Youth. Paediatrics & Child Health 2013;18(7 August/September):351-2.( www.ncbi.nlm.nih.gov/pubmed/24421706) 87. Ricketson LJ, Wood ML, Vanderkooi OG, MacDonald J, Martin IE, Demczuk WHB, Kellner JD. Trends in asymptomatic nasopharyngeal colonization with Streptococcus pneumoniae after introduction of the 13-valent pneumococcal conjugate vaccine in Calgary, Canada. Pediatric Infectious Disease Journal 2014:33(7):724-30. (Epub ahead of print Jan 23, 2014). (www.ncbi.nlm.nih.gov/pubmed/24463806) 88. Ricketson LJ, Vanderkooi OG, Wood ML, Leal, J, Kellner JD. Clinical Features and Outcomes of Serotype 19A Invasive Pneumococcal Disease in Calgary, Canada. Canadian Journal of Infectious Diseases and Medical Microbiology 2014;25(2 March/April):e71-5. 89. Bettinger JA, Vanderkooi OG, MacDonald J, Kellner JD, for PCIRN’s National Ambulatory Network. Rapid Online Identification of Adverse Events Following Influenza Immunization in Children by PCIRN’s National Ambulatory Network. Pediatric Infectious Disease Journal 2014;33(10):1060-4. (http://www.ncbi.nlm.nih.gov/pubmed/25361187)

James D. Kellner MD

26

90. Adamiak P, Vanderkooi OG, Kellner JD, Schryvers AB, Bettinger JA, Alcantara J. Effectiveness of the Standard and an Alternative Set of Streptococcus pneumoniae Multi-Locus Sequence Typing Primers. BMC Microbiology 2014 Jun 3;14(1):143 (www.ncbi.nlm.nih.gov/pubmed/24889110) 91. Stearns JC, Davidson CJ, McKeon S, Whelan FJ, Shah ME, Schryvers AB, Bowdish DME, Kellner JD, Surette MG. Maturation of Bacterial Communities in the Upper Respiratory Tract. The International Symposium on Microbial Ecology Journal (ISME J) 2015;9(5):1246-59. Epub 2015 January 9; doi:10.1038/ismej.2014.250. (http://www.ncbi.nlm.nih.gov/pubmed/25575312) 92. Waye A, Chuck AW, Jacobs P, Tyrrell G, Kellner JD. Prevnar 7 Childhood Immunization Program and Serotype Replacement: Changes in Pneumococcal Incidence and Resulting Impact on Health Care Costs in Alberta (2003-2008). Drugs – Real World Outcomes 2015;2(1). Published online May 5, 2015; DOI: 10.1007/s40801-015-0024-7.

93. Freedman SB, Lee BE, Louie M, Pang XL, Ali S, Chuck A, Chui L, Currie GR, Dickenson J, Drews SJ, Eltorki M, Graham T, Jiang X, Johnson DW, Kellner JD, Lavoie M, MacDonald J, MacDonald S, Svenson LW, Talbot J, Tarr P, Tellier R, Vanderkooi OG. Alberta  Provincial  Pediatric  EnTeric  Infection  TEam  (APPETITE):  Epidemiology,  Emerging  Organisms,  and  Economics. BMC Pediatrics 2015 Jul 31:15(1):89. DOI  10.1186/s12887-­‐‑015-­‐‑0407-­‐‑7.  

94.  Bettinger  JA,  Rouleau  I,  Gariepy  MC,  Bowie  WR,  Valiquette  L,  Vanderkooi  OG,  Kellner  JD,  Coleman  BL,  McNeil  SA,  McCarthy  A,  De  Serres  G,  Public  Health  Agency  of  Canada/Canadian  Institutes  for  Health  Research  Influenza  Research  Network  (PCIRN).  Successful  Methodology  for  Large-­‐‑Scale  Surveillance  of  Severe  Events  Following  Influenza  Vaccination  in  Canada,  2011  and  2012.  Eurosurveillance  2015  Jul  23;20(29):pii=21189.  

ii. Non Peer-Reviewed Manuscripts

1. Kellner JD, Kissoon N. Recognition and initial management of shock in children (invited review). Modern Medicine of Canada 1991:46(2):32-36.

2. Ford-Jones EL, Kellner JD. Congenital and perinatal infection: what the GP needs to know (invited review).Medicine North America January 1995.

3. Canadian Paediatric Society, Emergency Paediatrics Section (Kellner JD, member). Statement: Management of the paediatric patient with generalized convulsive status epilepticus in the emergency department. Paediatrics & Child Health 1996;1:151-5.

4. Sorokan ST, Kellner JD. Lumbar punctures in the first few days of life (invited review). Paediatrics & Child Health 1997;2:176-8.

5. Morris A, Kellner JD, Low DE. The superbugs: evolution, dissemination and fitness (invited review). Current Opinion in Microbiology 1998;1:524-9.

6. Kellner JD, Low DE. Antimicrobial resistant Streptococcus pneumoniae infections: clinical and epidemiological trends (invited review). McGill Journal of Medicine 1998;4:67-77.

7. Low DE, Kellner JD, Wright GD. Superbugs: how they evolve and minimize the cost of resistance (invited review). Current Infectious Disease Reports 1999;1:464-9.

8. Kellner JD. Drug-Resistant Streptococcus pneumoniae Infections: Clinical Importance, Drug Treatment and Prevention (invited review). Seminars in Respiratory Infections 2001;16:186-195.

9. Scheifele DW, Halperin SA, and Members of the CPS/Health Canada, Immunization Monitoring Program, Active (IMPACT) (Kellner JD, member). Immunization Monitoring Program, Active: A Model of Active Surveillance of Vaccine Safety. Seminars in Pediatric Infectious Diseases 2003;14:213-219.

James D. Kellner MD

27

10. Kellner JD. Review: Commonly Used Pharmacologic Treatments for Bronchiolitis in Children Do Not Seem to Be Effective (invited commentary). Evidence-Based Medicine 2004;9:141.

11. Kellner JD, Mandel, L. Pneumococcal Serotypes in the Elderly (invited editorial). Clinical Infectious Diseases 2005;41:488-9.

12. Navarro C, Kellner JD, Desai S. National Advisory Committee on Immunization Statement on the Recommended Use of Pneumococcal 23-Valent Polysaccharide Vaccine in Homeless Persons and Injection Drug Users. Canada Communicable Disease Report 2008;34(ACS-5):1-12. 13. Vanderkooi OG, Kellner JD (invited editorial). The challenge of reducing invasive pneumococcal disease in indigenous Indian populations. Clinical Infectious Diseases 2010;50:1247-8. (www.ncbi.nlm.nih.gov/pubmed/20367226)

14. Kellner JD, Canadian Pediatric Society Infectious Diseases and Immunization Committee. Update on the Success of Pneumococcal Conjugate Vaccine (invited “Practice Point” review). Paediatrics and Child Health 2011;16:233-6. (www.ncbi.nlm.nih.gov/pubmed/22468128)

iii. Books, Chapters, Theses

1. Kellner JD. Emergencies In: Shefler A, Ed. The Hospital for Sick Children Residents Handbook of Pediatrics. (8th Ed.) Toronto, B.C. Decker, 1991.

2. Kellner JD, Wang EEL. Cervical Adenitis. In: Johnson J, Yu V, ed. Infectious Diseases and Antimicrobial Therapy of the Ears, Nose and Throat. Philadelphia, WB Saunders, 1997.

3. Kellner JD. Streptococcus pneumoniae in child care centres: a point prevalence survey of nasopharyngeal carriage, antibiotic resistance and risk factors for resistance. Masters of Science (Clinical Epidemiology) thesis, Graduate Department of Community Health, University of Toronto, 1998.

4. Leung AK, Leung JS, Davies HD, Kellner JD. Rabies: Epidemiology, Pathogenesis, and Prophylaxis. In: Williamson JG, ed. Rabies: Symptoms, Treatment and Prevention. New York, Nova Science Publishers, Inc. 2010, p 33-47.

5. Leung AKC, Davies HD, Kellner JD. Pertussis in Adolescence. In: Berjardt LV, ed. Advances in Medicine and Biology – Volume 31. New York, Nova Science Publishers, Inc. 2012, p 177-91.

iv. Abstracts (Directly supervised trainees underlined)

1. Kellner JD, Rubin SZ. Pancreatitis in Infancy. Presented at the Pacific Association of Pediatric Surgeons Annual Meeting, Peurto Vallarta, Mexico, May 1986.

2. Robieux IC, Kellner JD, Olivieri NF, Coppes MJ, Brown EJ, Zipursky A, Koren G. Suboptimal Management of Pain Crises in Sickle Cell Disease: Prospective Observations. Presented at the American Society of Pediatric Hematology and Oncology, Annual Meeting, Chicago, USA, September 1989.

3. Robieux IC, Kellner JD, Coppes M, Shaw D, Brown E, Olivieri NF, Koren G, Zipursky A. Continuous intravenous infusion of morphine for the treatment of severe vaso-occlusive painful crises in children with sickle cell anemia. Journal of Pain and Symptom Management 1991;6(3):176. Presented at the Second International Symposium on Pediatric Pain, Montreal, April 1991.

4. Robieux IC, Kellner JD, Coppes MJ, Shaw D, Brown B, Olivieri NF, Koren G, Zipursky A. Continuous intravenous infusion of morphine for painful sickle cell crises. Pediatric Research 1991;29(4):149A. Presented at The Society for Pediatric Research Annual Meeting, New Orleans, Louisiana, May 1991.

James D. Kellner MD

28

5. Kellner JD, Moineau G, Bird L, Chauvin-Kimoff L, Jaffe D. Emergency department utilization: parent and patient attributes, beliefs and behaviors influencing use. Pediatric Emergency Care 1991;7:388.

6. Kellner JD, Moineau G, Bird L, Chauvin-Kimoff L, Jaffe D. Why not contact the usual doctor?: factors that influence visits to a pediatric emergency department. Clinical and Investigative Medicine (Supplement) 1992;15:A113. Poster presented at The Canadian Pediatric Society Annual Meeting, Ottawa, September 1992.

7. Kellner JD, Wang EL, Ohlsson A. Efficacy of bronchodilator therapy in bronchiolitis: a meta-analysis. Archives of Pediatrics and Adolescent Medicine 1994;148:40. Presented at the Ambulatory Pediatric Association Annual Meeting, Seattle, May 1994.

8. Jamieson F, Kellner JD, Wang E, Petric M. Torovirus-like particles (TVLPs) in pediatric gastroenteritis. Poster presented at 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Orlando, October 1994.

9. Jamieson F, Kellner JD, Bain C, Wang E, Petric M. Torovirus-like particles (TVLPs) in pediatric gastroenteritis. Poster presented at 62nd Canadian Association for Clinical Microbiology and Infectious Diseases Annual Meeting (CACMID), November 1994.

10. Wang EL, Ohlsson A, Kellner JD. Ureaplasma urealyticum colonization is associated with chronic lung disease of prematurity: results of a meta-analysis. Pediatric Research 1995;37(4):A277. Presented at The Society for Pediatric Research Annual Meeting, San Diego, May 1995.

11. Kellner JD, Ford-Jones EL, Ryan G. Hydrops fetalis caused by parvovirus B19: a decision analysis. Poster N7 presented at 35th ICAAC, San Francisco, September 1995.

12. Kellner JD, Ford-Jones EL, Matlow A, Low DE, Corey M, Watson H, Palmerino L, Gold R. Nasopharyngeal carriage of Streptococcus pneumoniae in children in daycare centres. Poster K017 presented at 36th ICAAC, New Orleans, September 1996.

13. Kellner JD, McGeer A, Wenger J, Talbot J, Matlow A, Low DE, Gold R, Ford-Jones EL. What is the correlation between population-based collections of invasive and nasopharyngeal isolates of Streptococcus pneumoniae ? Poster C049 presented at 36th ICAAC, New Orleans, September 1996.

14. Ford-Jones EL, Kellner JD, Silver MM, Ryan G, Kelly E, Heurter H, Olivieri NF, Freedman M, Doyle J, Laxer R, Zielinska M, Petric M. Association of acute human parvovirus B19 with clinical disease, The Hospital for Sick Children, 1987-1995. Poster H057 presented at 36th ICAAC, New Orleans, September 1996.

15. Kellner JD, Allen U, Ford-Jones EL, Matlow A, Low DE, Gold R. Comparison of Antibiotic Susceptibility Patterns of Nasopharyngeal Isolates of Streptococcus pneumoniae from children in Canada and Jamaica. Abstract published at 34th Infectious Diseases Society of America (IDSA) Annual Meeting, New Orleans, September 1996.

16. Kellner JD, Low DE, Ford-Jones EL, Matlow A, Corey M, Watson H, Palmerino L, Gold R. Trends in antibiotic resistance in nasopharyngeal (NP) strains of Streptococcus pneumoniae (SP) from children in daycare centres. Poster presented at 64th CACMID, Hamilton, Ontario, November 1996.

17. Kellner JD, McGeer A, Mahalingam E, Willey BM, Davies HD, Ford-Jones EL, Talbot J, Low DE. Relatedness of Nasopharyngeal (NP) Penicillin Nonsusceptible Streptococcus pneumoniae (PNSP) Isolates based on Serotypes and Pulsed-Field Gel Electrophoresis (PFGE) Patterns. Platform presentation C173 at 37th ICAAC, Toronto, September 1997.

18. Kellner JD, McGeer A, Mahalingam E, Willey BM, Davies HD, Ford-Jones EL, Talbot J, Schuchat A, Low DE. Relatedness of invasive pediatric Streptococcus pneumoniae isolates based on serotypes and pulsed-field gel eletrophoresis (PFGE) patterns. Poster K97 presented at 37th ICAAC, Toronto, September 1997.

19. Kellner JD, Gibb P, Rabin H. Concurrent invasive disease caused by penicillin resistant Streptococcus pneumoniae in three married couples. Poster LM-43 presented at 37th ICAAC, Toronto, September 1997.

James D. Kellner MD

29

20. Johnston NJ, De Azavedo J, Kellner JD, Low DE. Prevalence and characterization of the mechanisms of macrolide, lincosamide and streptogramin resistance in Streptococcus pneumoniae from across Canada. Poster C77a presented at 37th ICAAC, Toronto, September 1997.

21. Johnston NJ, De Azavedo J, Kellner JD, Low DE. In vitro methods for detection of mechanisms of macrolide resistance in Streptococcus pneumoniae. Poster D34 presented at 37th ICAAC, Toronto, September 1997.

22. Cunningham J, Kellner JD, Trevenen C, Bridge P, Davies HD. Pseudo-Gaucher cells in lymph nodes of infant with fatal Bacillus Calmette-Guérin infection. Poster LM13 presented at 37th ICAAC, Toronto, September 1997.

23. Luzod N, Laupland K, Karan T, Kellner JD, Taub D, Ma D, Kuhn S, Nijssen-Jordan C, Jadavji T, Church D, Davies HD. Clinical features of invasive pneumococcal (ISP) infections in children. Poster K99 presented at 37th ICAAC, Toronto, September 1997.

24. Davies HD, Laupland K, Kellner JD, Luzod N, Taub D, Karan T, Ma D, Nijssen-Jordan C, Church D, Jadavji T. Outcome of invasive pneumococcal (ISP) infections in hospitalized children. Poster K98 presented at 37th ICAAC, Toronto, September 1997.

25. McLeod DR, Anderson M, Kellner JD, Donckerwolcke R, Mueller D. Schimke immuno-osseous dysplasia: case report of siblings and review. Poster presented at Third International Skeletal Dysplasia Meeting, Los Angeles, August 1997.

26. Wang EEL, Einarson T, Kellner JD, Conly J. Antibiotic prescribing for respiratory tract infections in preschool children: analysis of the Saskatchewan Drug Database. Poster presented at the International Conference on Emerging Infectious Diseases, Atlanta, March 1998.

27. Wang EEL, Einarson T, Kellner JD, Conly J. Antibiotic prescribing for respiratory tract infections in preschool children: analysis of the Saskatchewan Drug Database. Poster presented at the Pediatric Academic Societies’ Annual Meeting, New Orleans, May 1998.

28. Mahalingam E, McGeer AJ, Low DE, de Azavedo J, Willey BM, Coulthart M, Davies HD, Ford-Jones EL, Talbot J, Kellner JD. Genetic similarities of multidrug-resistant Streptococcus pneumoniae isolates from serotypes 9V, 19F and 23F. Poster C31 presented at 38th ICAAC, San Diego, September 1998.

29. Kellner JD, Cunningham J, Ford-Jones EL, Low DE. Multidrug-resistant Streptococcus pneumoniae (MDRSP) in children: what antibiotics remain useful? Poster E19 presented at 38th ICAAC, San Diego, September 1998.

30. Kellner JD, Low DE, Talbot J, McGeer AJ. Population-based serotype patterns of invasive Streptococcus pneumoniae. Platform presentation L44 at 38th ICAAC, San Diego, September 1998.

31. Kellner JD, Mahalingam E, Low DE, Willey BM, Davies HD, Ford-Jones EL, Talbot J, McGeer AJ. Clonal variation of Streptococcus pneumoniae nasopharyngeal isolates within childcare centres. Platform presentation L46 at 38th ICAAC, San Diego, September 1998.

32. Kellner JD, Mahalingam E, Low DE, Willey BM, Davies HD, Ford-Jones EL, Talbot J, McGeer AJ. Clonal variation and invasiveness of Streptococcus pneumoniae isolates. Platform presentation L47 at 38th ICAAC, San Diego, September 1998.

33. Cunningham J, Ford-Jones EL, Low DE, Kellner JD. Multidrug-resistant Streptococcus pneumoniae (MDRSP) in children: what antibiotics remain useful? Poster presented at 66th CACMID, Toronto, November 1998.

34. Klassen TP, Ausejo M, Saenz A, Pham B, Kellner JD, Johnson DW, David M. Evaluating the effectiveness of glucocorticoids in the treatment of croup: a meta-analysis of randomized controlled trials. Platform presentation #199 at Pediatric Academic Societies Annual Meeting, San Francisco, May 1999.

35. Greenberg D, Mahenthiralingam E, Kellner JD, Campbell ME, Henry DA, Speert DP, Scheifele DS. Genotyping of penicillin-highly resistant invasive Streptococcus pneumoniae obtained from Canadian children early in the resistance epidemic. Poster presentation #941 at Pediatric Academic Societies Annual Meeting, San Francisco, May 1999. Pediatric Research 1999;45:161A.

James D. Kellner MD

30

36. Bagshaw S, Kellner JD. Attitudes, beliefs and behaviours of parents towards antibiotic use by their children. Poster presentation #400 at the Pediatric Academic Societies Annual Meeting, San Francisco, May 1999.

37. Klassen TP, Ausejo M, Saenz A, Kellner JD, Johnson D, Moher D. Evaluating the effectiveness of glucocorticoids in the treatment of croup. Platform presentation #19 at the Canadian Pediatric Society Annual Meeting, Winnipeg, June 1999. Paediatrics and Child Health 1999;4(Suppl B):46B.

38. Kellner JD, Low DE, Mahalingham E, Schuchat A, Willey BM, Landry LM, Goldenberg E, Toronto Invasive Bacterial Disease Network, McGeer AJ. Impact of reduced antimicrobial consumption on emergence of antimicrobial resistance in Streptococcus pneumoniae causing Invasive Infections. Poster presentation 1035 at 39th ICAAC, San Francisco, September 1999.

39. Thompson L, Fahie M, Young S, Jadavji T, Kellner JD, Kuhn S, Al Baksami O, Davies HD. Ambulatory parenteral antibiotic therapy program (APTT): alternative treatment model in a pediatric population. Poster presented at 37th Infectious Diseases Society of America Annual Meeting, Philadelphia, November 1999.

40. Kellner JD, Low DE, Mahalingham E, Schuchat A, Willey BM, Landry LM, Goldenberg E, Toronto Invasive Bacterial Disease Network, McGeer AJ. Emergence of Multidrug Resistant Streptococcus pneumoniae (MDRSP) During Population-Based Surveillance in Toronto, Ontario, Canada. Poster presented P86 at the Second International Symposium on Pneumococci and Pneumococcal Diseases, Sun City, South Africa, March 2000.

41. Kellner JD, Scheifele DW, Halperin SA, for Members of CPS/LCDC Immunization Monitoring Program, Active (IMPACT). Outcome of penicillin-nonsusceptible Streptococcus pneumoniae (PNSP) meningitis: a nested case-control study. Pediatric Research 2000;47(4, part 2):266A. Poster presentation at the Pediatric Academic Societies and American Academy of Pediatrics Combined Annual Meeting, Boston, May 2000.

42. Tan BJK, Davies HD and members of the Pediatric Investigators' Collaborative Network on Infections In Canada (PICNIC) (Kellner JD, member). Dexamethasone and antibiotic use for the empiric treatment of meningitis in Canadian children: a 1999 survey of infectious diseases specialists. Poster presentation at Canadian Pediatric Society Annual Meeting, Ottawa, June 2000.

43. Chawla R, Kellner JD, Semeniuk H, Church DL and Calgary S. pneumoniae Epidemiology Research (CASPER). Population-based surveillance of Streptococcus pneumoniae (SP) infections in Calgary, Alberta, Canada: Serotypes from invasive and lower respiratory tract isolates. Platform presentation #1441 at 40th ICAAC, Toronto, September 2000.

44. Chawla R, Kellner JD, Semeniuk H, Church DL and Calgary S. pneumoniae Epidemiology Research (CASPER). Population-based surveillance of Streptococcus pneumoniae (SP) infections in Calgary, Alberta, Canada: Influence of patient age and source of isolate on antibiotic susceptibility. Poster presentation #1807 at 40th ICAAC, Toronto, September 2000.

45. Cunningham JA, Kellner JD, Ford-Jones EL, Pong-Porter S, Argyris K, Low DE and Canadian Bacterial Surveillance Network (CBSN). Predicting Multidrug Nonsusceptible Streptococcus pneumoniae (MDNSP): Amoxicillin is "Number 1." Poster presentation #1805 at 40th ICAAC, Toronto, September 2000.

46. Jadavji N, Nijssen-Jordan C, Kellner JD, Macarthur C. Snowboarding injuries in Canadian children. Poster presentation at Canadian Conference on Injury Prevention and Control 2000, Kananaskis, Alberta, October 2000.

47. Dubey V, Kellner JD. A survey of anti-vaccine information on the Internet: more chaff than wheat. Platform presentation at 4th Canadian National Immunization Conference, Halifax, December 2000.

48. Kellner JD, McGeer AJ, Greenberg D, Willey B, Koscianski A, Low DE, Scheifele DW. Molecular epidemiology of invasive Streptococcus pneumoniae (SP) in Canadian children from 1991-1999. Poster presentation at 3rd International Pediatric Infectious Diseases Conference, Monterey, California, October 2001.

49. Wade AW, Vanderkooi O, Kellner JD, Jadavji T, Midgley JP, Louie T, Tyrrell GT. Short period of acute renal failure in 2 children with Streptococcus pneumoniae Haemolytic Uremic Syndrome (HUS) who received only

James D. Kellner MD

31

washed blood products. Poster presentation at Canadian Society of Nephrology Annual Meeting, Ottawa, March 2002.

50. Vanderkooi OG, Kellner JD, Wade AW, Jadavji T, Midgley JP, Louie T. Invasive Streptococcus pneumoniae infection causing hemolytic uremic syndrome (HUS) in children: two recent cases in Calgary, Canada. Poster presentation at 3rd International Symposium on Pneumococci and Pneumoccocal Diseases, Anchorage, Alaska, May 2002.

51. Skowronski DM, De Serres G, Warrington R, Russell ML, Davies D, Kellner JD, MacDonald J, Scheifele D. Oculo-respiratory syndrome following influenza vaccine: recurrence risk with re-formulated vaccine for 2001-2002. Platform presentation at 5th Annual Conference on Vaccine Research, Baltimore May 2002.

52. Kellner JD, Aufricht P, McIsaac WJ, Bucholtz L, Vanjaka A, Low DE. Use of Both a Clinical Score and Rapid Antigen Test Improves the Bedside Diagnostic Accuracy to Detect Group A Streptococcus (GAS) Sore Throats. Poster D-121 presented at 42nd ICAAC, San Diego, September 2002.

53. Kellner JD, Low DE, McIsaac WJ, Bucholtz L, Vanjaka A, Aufricht P. High Levels of Antibiotic Resistance in Viridans Group Streptococci (VGS) Found in Throat Cultures from Persons in the Community: An Important Reservoir of Resistance. Poster C2-1991 presented at 42nd ICAAC, San Diego, September 2002.

54. Kellner JD, Semeniuk H, Elsayed S, Church D. Increasing Invasive Streptococcus pneumoniae (ISP) infections in Children before the Introduction of Conjugate Vaccine in Calgary, Canada. Calgary S. pneumoniae Epidemiology Research (CASPER). Poster G-845 presented at 42nd ICAAC, San Diego, September 2002.

55. Vayalumkal J, Kellner JD. Survey of Canadian Physicians about Tympanocentesis (TYMP) in the Management of Otitis Media (OM) in Children. Poster presentation at 40th IDSA, Chicago, October 2002.

56. Alhussaini A, Butzner D, Kellner J, Robertson M. Herpes Simplex Ulcerative Esophagitis in Healthy Children. Poster presentation at North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) 15th Annual Meeting, San Antonio, Texas, October 2002.

57. Scheifele D, Law B, Vaudry W, Halperin S, Kellner JD, King A, Dawar M for Members of the Immunization Monitoring Program, Active (IMPACT). Invasive Pneumococcal Infections among Aboriginal Children in Canada, 1991-2001. Poster presentation at 5th Canadian National Immunization Conference, Victoria, December 2002.

58. Millar K, Kellner JD, Tingley R, Johnson D. Peritonsillar Abscess in Children in Calgary. Poster presentation at Pediatric Academic Societies Annual Meeting, Seattle, May 2003.

59. Daley P, Church DL, Hamilton N, Gregson DB, Pitout JDD, Kellner JD, Elsayed S. Experience with Molecular Speciation of Invasive Streptococcus milleri group (SMG) Clinical Isolates Using Nucleic Acid Sequencing (NAS) in a Centralized Regional Microbiology Laboratory. Poster presentation at 103rd General Meeting American Society for Microbiology, Washington, May 2003.

60. Chawla R, Church DL, Kwok HY, Kellner JD. Clinical Features And Outcome Of Bacteremic Pneumococcal Pneumonia (BPP) Compared With Non-Bacteremic Pneumococcal Pneumonia (NBPP). Platform presentation L-465 at 43rd ICAAC, Chicago, September 2003.

61. Baril L, Greenberg, Gayet A, Taha M, Caugant DA, Collaborative Meningococcal Disease Study Group (Kellner JD, member). Clinical and Microbiological Aspects of Invasive Meningococcal Disease (IMD) in Children and Adolescents from 7 Countries. Poster presentation G-1553 at 43rd ICAAC, Chicago, September 2003. 62. Kellner JD, MacDonald J, Church DL, Scheifele D, Tyrrell G. CASPER (Calgary Area S. pneumoniae Epidemiology Research). A Model to Study the Impact of Pneumococcal Conjugate Vaccine on Asymptomatic Nasopharyngeal (NP) Carriage of S. pneumoniae (SP) in Calgary, Canada. Poster presentation COL-21 at Fourth International Symposium on Pneumococci and Pneumococcal Diseases, Helsinki, 2004.

James D. Kellner MD

32

63. Harris K, Conly J, Heule L, Dersch D, Gregson D, Kellner JD, Laupland K, Long S, Louie T, Mah M, Thomas R, Rumbles T. An Evaluation of the Use of the Liposomal and Lipid Amphotericin B Formulations in the Calgary Health Region. CIDS/CAMM/CHIC Annual Meeting, Calgary, May 2004.

64. Heule L, Boulter L, Conly J, Dersch D, Gregson D, Kellner JD, Laupland K, Long S, Louie T, Mah M, Thomas R, Rumbles T. Monitoring Of Antimicrobial Utilization Patterns In An Integrated Health Region. Poster presentation at the CIDS/CAMM/CHIC Annual Meeting, Calgary, May 2004.

65. Smart K, Lemay JF, Kellner JD. Antibiotic Choices by Pediatric Residents and Recently Graduated Pediatricians in Common Infectious Diseases Problems in Children. Poster Presentation at 81st Canadian Pediatric Society Annuual Meeting, Montreal, June 2004.

65. Desai SN, Kellner JD, Shevchuk YM, Wang, EEL, Conly JM. Antibiotic Prescribing for Respiratory Tract Infections has Decreased in Canadian Children: is it All Good News? Poster presentation G-514 at 44th ICAAC, Washington, October 2004.

66. Powis JE, Church D, MacDonald J, Scheifele D, Pitchko J, Rose S, Tyrrell G, Green KA, Vanderkooi O, Low DE, McGeer A, Kellner JD. Impact of Differing Provincial Pneumococcal Vaccination Programs on Invasive Pneumococcal Disease in Children. Platform presentation G-1672 at 44th ICAAC, Washington, October 2004.

67. Miettunen PMH, Kaura D, Abou-Reslan WF, Kellner JD. Effective Treatment of Chronic Recurrent Multifocal Osteomyelitis (CRMO) with IV Pamidronate: Two Case Reports. Poster presentation 1397/219 at American College of Rheumatology Annual Scientific Meeting, San Antonio Texas, October 2004.

68. Kellner JD, Pitchko J, MacDonald J, Church D, Scheifele D, Tyrrell G. Nasopharyngeal Streptococcus pneumoniae Colonization with Vaccine & Related Serotypes and Non-Vaccine & Related Serotypes in Healthy Children after Introduction of Pneumococcal Conjugate Vaccine in Calgary, Canada. Poster presentation #1381 (Session 5477) at Pediatric Academic Societies Annual Meeting, Washington, DC, May 2005. 69. Langley JM, Kellner JD, Robinson J, Solomon N, Le Saux N, Tan B, McDonald J, Ulloa-Gutierriz R, Allen U. Empyema Associated with Community-Acquired Pneumonia: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) Study. Poster presentation 561 at 43rd Infectious Diseases Society of America Annual Meeting, San Francisco, October, 2005. 70. Kellner JD, Church DL, MacDonald J, Scheifele D , Tyrrell GJ, Vanderkooi OG. Streptococcus pneumoniae (SP) Nasopharyngeal (NP) Colonization: Trends Over Three Years After Introduction of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Canada. Poster Symposium VII. 5th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD5). Alice Springs, Australia, April 2006. 71. Kellner JD, Church DL, MacDonald J, Scheifele D , Tyrrell GJ, Vanderkooi OG. Serotype Replacement in Invasive Streptococcus pneumoniae (ISP) Infections After Introduction of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Canada: Implications For An Expanded 13-Valent Conjugate Vaccine. Poster Symposium X (Part 1). 5th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD5). Alice Springs, Australia, April 2006. 72. Vanderkooi OG, Church DL, MacDonald J, Scheifele D , Tyrrell GJ, Kellner JD. Invasive Streptococcus pneumoniae (ISP) Infections Continue to Cause High Mortality. Poster Symposium IV. 5th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD5). Alice Springs, Australia, April 2006. 73. Langley JM, Kellner JD, Robinson J, Solomon N, Le Saux N, Tan B, McDonald J, Ulloa-Gutierriz R, Allen U. Empyema Associated with Community-Acquired Pneumonia: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) Study. Poster #109 at 83rd Canadian Pediatric Society Annual Conference, St. John’s Newfoundland, June 2006. 74. Hering R, Yacoub WR, Richardson R, Kellner JD. Knowledge, Attitudes and Barriers to Childhood Vaccinations In On-Reserve First Nations Communities in Southern Alberta. Poster presentation P65 at 7th Canadian Immunization Conference, Winnipeg, December 2006. Canadian Journal of Infectious Diseases and Medical Microbiology 2006;17:373.

James D. Kellner MD

33

75. Langley J, Kellner JD, Robinson J, Le Saux N, Tan B, Ulloa-Gutierrez R, Allen U. Vaccine-Preventable Empyema Due to Community-Acquired Pneumonia in Canadian Children: A Pediatric Investigators’ Collaborative Network on Infections in Canada (PICNIC) Study. Platform presentation O22 at 7th Canadian Immunization Conference, Winnipeg, December 2006. Canadian Journal of Infectious Diseases and Medical Microbiology 2006;17:353. 76. Tyrrell GJ, Lovgren M, MacDonald J, Johnson M, Virani S, Kellner JD. Outbreak of Streptococcus pneumoniae serotype 5 in Alberta, Canada. 2nd Annual Public Health Agency of Canada (PHAC) Research Forum, Winnipeg, March 2007. 77. Casciano R, Doyle J, Kellner JD, Dolgister M, Stern L, Krukas MR, Fontaine L, Vincente C. Pharamcoeconomic Evaluation of Herd Immunity Conferred by Seven-Valent Pneumococcal Conjugate Vaccine (Prevnar) in Canada Based on Calgary Region Epidemiological Data. Value in Health 2007;10(3 May):A164-5. 78. Twele L, Tyrrell G, Vanderkooi OG, MacDonald J, Church D, Scheifele D, Kellner JD. Outbreak Of Serotype 5 (ST5) Invasive Pneumococcal Disease (IPD) In Predominantly Homeless Middle-Aged Persons In Calgary, Canada. Poster presentation #L-1155 at 47th ICAAC, Chicago, September 2007. 79. Kellner JD, Vanderkooi OG, MacDonald J, Church D, Tyrrell G, Scheifele D. Shift In Serotypes Causing Invasive Pneumococcal Disease (IPD) After The Introduction Of 7-Valent Pneumococcal Conjugate Vaccine (PCV7): Implications For Expanded Valency Vaccines. Poster presentation #G-994 at 47th ICAAC, Chicago, September 2007. 80. Hsieh Y-C, Huang L-M, Byington C, Kellner JD, Obando I, Fletcher M, Spencer D. Pediatric Parapneumonic Empyema and Complicated Pneumonia Before and After Introduction of Pneumococcal Conjugate Vaccine (PCV7, Prevenar). Poster presentation at Fifth World Congress, World Society for Pediatric Infectious Diseases, Bangkok, Thailand, November 2007. 81. VanderPluym C, Tawfik G, Hervas-Malo M, Lacaze-Masmonteil T, Kellner JD, Robinson J. Empiric Therapy of Possible Neonatal Herpes Simplex Virus Infection in Edmonton, Alberta. Poster presentation at 2008 Pediatric Academic Societies’ Meeting, Honolulu, Hawaii, May 2008. 82. Lovgren M, Tyrrell G, Kellner JD, Hoang L, Horsman G, van Caseele P. Outbreak of Streptococcus pneumoniae Serotype 5 in Western Canada. Poster presentation P1019 at Alberta Provincial Laboratory of Public Health Scientific Symposium, Edmonton, May 2008. 83. Vanderkooi OG, Church DL, MacDonald J, Tyrrell G, Kellner JD. Trends in Antimicrobial Resistance of Invasive and Lower Respiratory Tract Streptococcus pneumoniae (SP) Isolates in Calgary, Canada, 1998 – 2006. Poster presentation at the 6th International Symposium on Pneumococci & Pneumococcal Diseases (ISPPD), Reykjavik, Iceland, June 2008. 84. Byington CL, Pirez MC, Hsieh Y-C, Huang L-M, Kellner JD, Obando I, Fletcher MA, Spencer D. Pediatric Parapneumonic Empyema and Complicated Pneumonia Before, During, and After Introduction of 7-valent Pneumococcal Conjugate Vaccine (PCV7, Prevenar™). Poster presentation at the 6th International Symposium on Pneumococci & Pneumococcal Diseases (ISPPD), Reykjavik, Iceland, June 2008. 85. Marrie TK, Tyrrell GJ, Kellner JD and the SPAT (Streptococcus pneumoniae Alberta Team) Group. Age Dependent Epidemiology of Invasive Pneumococcal Disease. Poster presentation at the 6th International Symposium on Pneumococci & Pneumococcal Diseases (ISPPD), Reykjavik, Iceland, June 2008. 86. Marrie TK, Garg S, Tyrrell GJ, Kellner JD and the SPAT Group. Factors Predicting Mortality in Invasive Pneumococcal Disease (IPD). Poster presentation at the 6th International Symposium on Pneumococci & Pneumococcal Diseases (ISPPD), Reykjavik, Iceland, June 2008. 87. Bradshaw B, Boone TJ, Lovgren M, Chui L, Marrie TK, Kellner JD, Tyrrell GJ. Clonal groups of Streptococcus pneumoniae in Alberta: An RFLP Snapshot From The SPAT Study. Poster presentation at the 6th International Symposium on Pneumococci & Pneumococcal Diseases (ISPPD), Reykjavik, Iceland, June 2008.

James D. Kellner MD

34

88. Tyrrell GJ, Marrie TK, Garg S, Kellner JD and the SPAT Group. Description of Pneumococcal Meningitis in a Large Canadian Population Pre and Post PCV7 Introduction. Poster presentation at the 6th International Symposium on Pneumococci & Pneumococcal Diseases (ISPPD), Reykjavik, Iceland, June 2008. 89. Tyrrell GJ, Lovgren M, Kellner JD, Grimsrud K, Hoang L, Patrick D, Horsman G, van Caeseele P, and the Serotype 5 Invasive Pneumococcal Investigation Team. A Large Outbreak of Invasive Streptococcus pneumoniae Serotype 5 in Western Canada. Platform presentation at the 6th International Symposium on Pneumococci & Pneumococcal Diseases (ISPPD), Reykjavik, Iceland, June 2008. 90. Wong  A,  Marrie  TJ,  Kellner  JD,  Tyrrell  GJ and  the  SPAT  Group.  Increased  incidence of  invasive  pneumococcal  disease  in  patients  with underlying  malignancy.  Poster  presentation  at  48th  ICAAC,  Washington,  DC,  October  2008. 91. Wong  A,  Marrie  TJ,  Kellner  JD,  Tyrrell  GJ and  the  SPAT  Group.  Association  between occupation  and  invasive  pneumococcal  disease:  welders are  at  increased  risk.  Poster  presentation  at  48th  ICAAC,  Washington,  DC,  October  2008. 92. Chuck A, Jacobs P, Nguyen T, Hnarahan A, Loewen J, Mashinter L, Ohinmaa A, Zhang J, Vaudry W, Kellner JD. Economic Analysis of a Public Program for Routine Seven Valent Pneumococccal Conjugate Vaccine (PCV-7) in Infancy. Poster presentation P42 at the 8th Canadian Immunization Conference, Toronto, December 2008. 93. Kellner JD, Girgenti D, Halperin SA, Scheifele D, Gruber WC, Scott D. Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants Given with Routine Pediatric Vaccinations in Canada. Platform presentation at Twelfth Annual Conference on Vaccine Research sponsored by the National Foundation for Infectious Diseases, Baltimore, April 2009. 94. Twele L, Haider S, Nettel-Aguirre A, Reslan A, Belanger F, Kellner JD. Has the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) Reduced Hospital Visits and Admissions in Young Children in Calgary? Platform Presentation at 26th International Congress on Chemotherapy, Toronto, June 2009. 95. Kellner JD, Halperin SA, Scheifele D, Connor DD, Dionne M, McDonald JC, Meekison WG, Predy G, Rubinstein E, Tapiero B, Zickler P. Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants Given with Routine Pediatric Vaccinations in Canada. Poster presentation at 86th Canadian Pediatric Society Annual Conference, Ottawa, June 2009. 96. Kellner JD, Halperin SA, Scheifele D, Connor DD, Dionne M, McDonald JC, Meekison WG, Predy G, Rubinstein E, Tapiero B, Pride M, Patterson S, Girgenti D, Gruber W, Emini E, Scott D, Zickler P. Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given with Routine Pediatric Vaccinations in Canada. Poster presentation at 7th International Symposium on Pneumococci & Pneumococcal Diseases (ISPPD), Tel Aviv, Israel, March 2010. 97. Bettinger JA, Scheifele DW, Kellner JD, Vaudry W, Halperin SA, Law B, Tyrrell G. Emergence of Serotype 19A in Canadian Children: IMPACT 2000-2009. Oral Presentation at 9th Canadian Immunization Conference, Quebec City, December 2010. Canadian Journal of Infectious Diseases & Medical Microbiology 2010;21:178. 98. Scheifele DW, Ward B, Dionne M, De Serres G, Langley J, Halperin S, Vanderkooi O, Kellner JD, Dobson S, Sauve L, Li Y, Law B. One Dose or Two? Results of a PCIRN Study of Dosing Requirements of Toddlers Given Adjuvented H1N1 Vaccine During the 2009 Pandemic. Oral Presentation at 9th Canadian Immunization Conference, Quebec City, December 2010. Canadian Journal of Infectious Diseases & Medical Microbiology 2010;21:181. 99. Scheifele DW, Dionne M, De Serres G, Loeb M, McGeer, A, Vanderkooi O, Kellner JD, Dobson S, Sauve L, Li Y, Law B, Halperin S. PCIRN Study of Adults Given Monovalent, Adjuvanted H1N1 Vaccine with Concurrent or Delayed Trivalent Seasonal Influenza Vaccination. Poster Presentation at 9th Canadian Immunization Conference, Quebec City, December 2010. Canadian Journal of Infectious Diseases & Medical Microbiology 2010;21:226. 100. Bettinger JA, Scheifele DW, Halperin SA, Kellner JD, Schryvers A, De Serres G, Alcantara J. Evaluation of Meningococcal C Conjugate Vaccine Programs in Canadian Children: Interim Analysis. Poster presentation at 5th Vaccine and ISV Annual Global Congress, Seattle, October 2011.

James D. Kellner MD

35

101. Langley J, Scheifele DW, Quach C, Vanderkooi O, Dobson S, McNeil S, MacKinnon-Cameron D, Ward B, Kuhn S, Kollmann T, Smith B, Halperin S, Kellner JD. Safety and Immunogenicity of 2010-2011 H1N12009-Containing Trivalent Inactivated Influenza Vaccine (TIV) in Young Children 12 to 59 Months of Age (YC) Who Received AS03-Adjuvanted H1N12009 Pandemic Vaccine; a PHAC/CIHR (PCIRN) Influenza Research Network Study. Poster presentation at 49th IDSA, Boston, October 2011. 102. Leal J, Vanderkooi OG, Church DL, MacDonald J, Tyrrell GJ, Kellner JD. Eradication of Invasive Pneumococcal Disease (IPD) due to the 7-valent Pneumococcal Conjugate Vaccine (PCV7) Serotypes in Calgary, Alberta. Poster presentation at 49th IDSA, Boston, October 2011. 103. Vanderkooi OG, Ricketson LJ, Scheifele DW, Church D, MacDonald J, Martin I, Kellner JD. Serotype-Specific Trends in Pneumococcal Nasopharyngeal Colonization Before and After PCV7 and PCV13 Vaccine Programs in Calgary, Canada. Oral Poster Presentation at 8th International Symposium on Pneumococci & Pneumococcal Diseases (ISPPD), Iguacu Falls, Brazil, March 2012. 104. Ricketson LJ, Vanderkoi OG, Nettel-Aguirre A, Laupland KB, Kellner JD. Early and Late Mortality in Adults with Invasive Pneumococcal Disease (IPD) in Calgary, Canada. Oral Presentation at 8th ISPPD, Iguacu Falls, Brazil, March 2012. 105. Ricketson LJ, Wood ML, Leal J, Vanderkooi OG, Kellner JD, CASPER Investigators. Clinical Features and Outcomes of Serotype 19A (ST19A) Invasive Pneumococcal Disease (IPD) in Calgary, Canada. Poster Presentation at 8th ISPPD, Iguacu Falls, Brazil, March 2012. 106. Feikin D, Moore M, Serotype Replacement Study Team (Kellner JD member). A Multi-Site Analysis of Serotype-Specific Changes in Invasive Pneumococcal Disease After Conjugate Vaccine Introduction Among Children <5 Years Old. Oral Presentation at 8th ISPPD, Iguacu Falls, Brazil, March 2012. 107. Moore M, Feikin D, Serotype Replacement Study Team (Kellner JD member). A Multi-Site Analysis of Serotype-Specific Changes in Invasive Pneumococcal Disease After Conjugate Vaccine Introduction Among Children ≥5 Years Old. Oral Presentation at 8th ISPPD, Iguacu Falls, Brazil, March 2012. 108. Chuck AW, Waye A, Zanotti G, Jacobs P, Tyrrell G, Kellner JD. Pharmacoeconomic evaluation of 13-Valent Pneumococcal Conjugate and 23-Valent Pneumococcal Polysaccharide Vaccine in Canadian Adults. Oral Presentation at Canadian Association for Population Therapeutics, Montreal, May 2012. J Popul Ther Clin Pharmacol 2012, 19(2): e120. 109. Ricketson LJ, Vanderkooi OG, MacDonald J, Kellner JD, for the CASPER Investigators. Epidemiology of Invasive Pneumococcal Disease in Calgary, Alberta Before and After PCV7 and PCV13 Vaccine Introduction. Poster presentation at 9th ISPPD, Hyderabad, India, March 2014. 110. Ricketson LJ, Conradi NG, Vanderkooi OG, MacDonald J, Kellner JD, for the CASPER Investigators. Changes in the Nature and Severity of Invasive Pneumococcal Disease in Children, Before and After the 7-Valent Protein-polysaccharide Conjugate Vaccine Program in Calgary, Canada. Poster presentation at 9th ISPPD, Hyderabad, India, March 2014. 111. Ricketson LJ, Wood ML, Vanderkooi OG, MacDonald JC, Martin IE, Demczuk WHB Kellner JD. Trends in Asymptomatic Nasopharyngeal Colonization with Streptococcus pneumoniae After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Calgary, Canada. Poster presentation at 9th ISPPD, Hyderabad, India, March 2014. 112. Waye A, Chuck AW, Jacobs P, Tyrrell G, Kellner JD. Economic Impact of Alberta’s PCV7 Childhood Immunization Program (2003-2008). Poster presentation at 19th Annual International Society for Pharmacoeconoomics and Outcomes Research (ISPOR) Meeting, Montreal, June 2014. 113. Demczuk W, Singh R, Hoang L, Kellner JD, Horsman G, VanCaeseele P, Gubbay J, Lefebvre B, Haldane D, Garceau R, Ratnam S, German G, Martin I. Multi-Locus Sequence typing for the Differentiation of Prevalent and Emerging Streptococcus pneumonia Serotypes. Poster presentation #247 at Session #11, XIX Lancefield International Symposium on Streptococci and Streptococcal Diseases, Buenos Aires, Argentina, November 2014.

James D. Kellner MD

36

114. Cabaj J, MacDonald J, Nettel-Aguirre A, Vanderkooi A, Kellner JD. The Influence of Childhood Conjugate Vaccine Introduction on Invasive Pneumococcal Disease (IPD) in Adults with Underlying Comorbidities. Poster presentation #53 at Canadian Immunization Conference, Ottawa, December, 2014. v. Communications

1. Kellner JD. Fever and petechiae in children (letter, not peer-reviewed). Pediatrics 1990;86:807.

2. Kellner JD. Priorities for the use of finite resources (letter, not peer-reviewed). Journal of Pediatrics 1990;116:843.

3. Wang EL, Kellner JD. Albuterol vs. racemic epinephrine in acute bronchiolitis (invited comment, not peer-reviewed). Pediatric Emergency and Critical Care 1995;8:25-26.

4. Ford-Jones EL, Kellner JD. "CHEAP TORCHES:" A better acronym when considering congenital and perinatal infections (letter, peer-reviewed). Pediatric Infectious Diseases Journal. 1995;14:638-40.

5. Kellner JD. Oral dexamethasone in acute bronchiolitis (invited comment, not peer-reviewed). Pediatric Emergency and Critical Care 1997;10:13-14.

6. Wang EE, Kellner JD, Ohlsson A, Gadomski A. Updated bronchodilator analysis (letter, not peer-reviewed). Archives of Pediatrics & Adolescent Medicine 1999;153:430.

7. Richardson SE, Jarvis DA, Kellner JD, Ford-Jones EL. Pneumococcal disease in children. Canadian Pediatric Society News 2000;March/April:11.

8. Scheifele D, Kellner JD, Tapiero B, de Wals P. Emerging trends in S. pneumoniae and childhood illness. Medical Post Colloquium 2001;Jan.

9. Kellner JD. Short Course Antibiotic Therapy for Pediatric Respiratory Tract Infections. Patient Care Magazine and L’Actualite Medicale 2001;Nov.

10. De Wals P, Petit G, Erickson LJ, Guay M, Tam T, Law B, Framarin A. Benefits and Costs of Immunization of Infants with Pneumococcal Conjugate Vaccine in Canada. Report submitted to the Quebec Agency for Health Services and Technology Assessment, July 2001. (Kellner JD, acknowledged as Delphi panel expert advisor and contributed incidence data.)

11. Scheifele D, Halperin S, Pelletier L, Talbot J, Lovgren M, Vaudry W, Jadavji T, Law B, MacDonald N, Gold R, Wang E, Mills E, Lebel M, Déry P, Morris R. Reduced Susceptibility to Penicillin among Pneumococci Causing Invasive Infection in Children – Canada, 1991 to 1998. Canadian Journal of Infectious Diseases 2001;12:241-6. (Kellner JD acknowledged for editorial assistance.)

12. Kellner JD. Issues in the Antimicrobial Treatment of Respiratory Tract Infections in Children. In: Addressing the Issues – Therapeutic Management of Acute Exacerbations of Chronic Bronchitis, Community-Acquired Pneumonia and Acute Otitis Media. Université Laval Educational CD-ROM 2001.

13. Olgilvie C, Omikunle A, Wang Y, St. Geme III J, Rodriguez CA, Adderson EE. Capsulation Loci of Non-Serotype b Encapsulated Haemophilus influenzae. (Kellner JD acknowledged for contribution of strain.)

14. Kellner JD. Management of Pediatric Respiratory Tract Infections: Short-Course Antibiotic Therapy and Other Issues. In: McGill Interactive Lecture Series in Microbiology. Educational CD-ROM 2002.

15. Kellner JD. Exchanges in Pediatric Infection. A Practical Q & A for Disease Management. Parkhurst Exchange 2002;April.

16. National Advisory Committee on Immunization. Statement on Recommended Use of Pneumococcal Conjugate Vaccine. Canada Communicable Disease Report 2002;28(ACS-2):1-32. (Kellner JD, acknowledged for assistance and contribution of incidence rate data.)

James D. Kellner MD

37

17. Hollingshead S, Baril L, Ferro S, Punar M, King J. Pneumococcal Surface Protein A (PspA) Distribution among Invasive Pneumococcal Isolates from Adults over 50 Years of Age. Platform presentation G-1072 at 42nd ICAAC, San Diego, September 2002 (Kellner JD acknowledged for collaboration and contribution of cases.)

18. Robinson DA, Briles DE, Crain MJ, Hollingshead SK. Evolution and Virulence of Serogroup 6 Pneumococci on a Global Scale. Journal of Bacteriology 2002;184:6367 (http://jb.asm.org/cgi/content/full/184/22/6367?view=long&pmid=12399507). (Kellner JD acknowledged for collaboration in donation of bacterial isolates.)

19. Kellner JD, Ward R. Clinical Focus: Management of Acute Otitis Media. Medical Post 2002;November 11.

20. Kellner JD. Ear Infections: A Parent’s Guide to Otitis Media. Today’s Parent Magazine Dec/Jan 2003, Glow Magazine Winter 2002/03 and enfants Québec Dec/Jan 2003.

21. Kellner JD, MacCormick J, Poupart R, Rubin EE, Ward RA. Current Issues in the Treatment of Pediatric Otitis Media. VoxMedic Educational CD-ROM and Webcast CME, 2003.

22. Kellner JD. Considerations for Therapy of Otitis Media in Children. In Monograph: Pediatric Short-course Antimicrobial Therapy. Toronto, Excerpta Medica Canada, 2003.

23. Johnson DW, Croup Working Group (Kellner JD, member). Guideline for the Diagnosis and Management of Croup. Alberta Clinical Practice Guidelines. Alberta Medical Association, Edmonton.

24. De Wals P, Petit G, Erickson LJ, Guay M, Tam T, Law B, Framarin A. Benefits and Costs of Immunization of Children with Pneumococcal Conjugate Vaccine in Canada. Vaccine 2003;21:3757-64. (Kellner JD acknowledged for contribution of epidemiologic data and participation in Delphi consultation.)

25. Petit G, De Wals P, Law B, Tam T, Erickson LJ, Guay M, Framarin A. Epidemiological and Economic Burden of Pneumococcal Diseases in Canadian Children. Can J Infect Dis 2003;14:215-20 (www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2094937). (Kellner JD acknowledged for contribution of epidemiologic data.)

26. Low DE, Weiss KA, Kellner JD, Poisson M, Rotstein C, Marrie TJ. Streptococcus pneumoniae Resistance and Antibiotic Use in Community Acquired Pneumonia: A Canadian Perspective. Tamarind Healthcare Communications. 2004.

27. Kellner JD. Pseudomonas aeruginosa Pre-Septal Cellulitis and Bacteremia in a Pediatric Oncology Patient. (letter, not peer-reviewed) Pediatric Blood and Cancer 2005;45:354.

28. Kellner JD, Hastie L, Hui S, Pitchko J, Vanderkooi O, MacDonald J, Church D, Tyrrell G, Scheifele D. Outbreaks of Serotype 5 and Serotype 8 Invasive Pneumococcal Disease in Calgary, Alberta, Canada. (Posting, not peer-reviewed). ProMED-mail 2006;Dec 14 (Archive number 20061214.3520, www.promedmail.org).

29. Morrow A, De Wals P, Petit G, Guay M, Erickson LJ. The Burden of Pneumococcal Disease in the Canadian Population Before Routine Use of the Seven-Valent Pneumococcal Conjugate Vaccine. Can J Infect Dis Med Microbiol 2007;18:121-7 (www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=18923713). (Kellner JD acknowledged for contribution of epidemiologic data.)

30. GAVI’s PneumoADIP. Pneumococcal Regional Serotype Distribution for Pneumococcal AMC TPP: Codebook to assess whether a pneumococcal vaccine meets the Pneumococcal AMC Target Product Profile for regional vaccine serotype coverage. Prepared by GAVI’s PneumoADIP, Department of International Health, Johns Hopkins Bloomberg School of Public Health, November 30, 2008 (www.vaccineamc.org/updatedec_08.html). (Kellner JD acknowledged for sharing unpublished data and for membership on the GSP (Global Serotype Project) Expert Committee.

31. Scheifele D, Halperin S, Skowronski D, Kellner JD, Ward B, Gemmill I, De Serres G. Regrettable Lack of Definition of the “Well Tolerated” Vaccine (letter to the editor). Vaccine 2010;28:3755-6.

James D. Kellner MD

38

32. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Hance LF, Reithinger R, Muenz LR, O’Brien KL. Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project. PLoS Medicine 2010;7(10):e1000348(1-13). (Kellner JD acknowledged for providing data and participating on External Expert Committee of the Pneumococcal Global Serotype Project.)

33. Talbird SE, Taylor TN, Knoll S, Frostad CR, Martíe SG. Outcomes and Costs Associated with Phid-CV, a New Protein D Conjugate Pneumococcal Vaccine, in Four Countries. Vaccine 2010;28 (Suppl 6):G23-9. (Kellner JD acknowledged for contributions to inform the economic model.)

34. Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report (2010, October 22). Weekly Epidemiological Record 2010:43:434-6 (www.who.int/wer/2010/wer8543.pdf). (Kellner JD member of expert consultation group.)

35. Siemieniuk RAC, Gregson DB, Gill MJ. The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study. BMC Infectious Diseases 2011;11:314 (http://www.biomedcentral.com/1471-2334/11/314). (Kellner JD acknowledged for contributions.)

36. Quach-Thanh, Thomas H for the National Advisory Committee on Immunization (NACI). An Advisory Committee Statement: Statement on the Use of Conjugate Pneumococcal Vaccine – 13 Valent in Adults (Pneu-C-13). Canada Communicable Disease Report 2013:39(ACS-5):1-52 (http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/13vol39/acs-dcc-5/index-eng.php). (Kellner JD acknowledged for contributions.)

37. MacDonald SE, Dover DC, Simmonds KA, Svenson LW. Fisk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study. Canadian Medical Association Journal 2014;186(11):824-9 (www.ncbi.nlm.nih.gov/pubmed/24914115). (Kellner JD acknowledged for guidance and support.)